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ABSTRACT
The benefits of exercise training on endothelial function in the healthy young population are
unclear. This study was designed to assess the effects of sprint interval training (SIT; 4-7 x
30-45 s all out exercise efforts separated by 4 min of recovery, repeated 3-4 times/wk over 6
wk) on endothelial function of the superficial femoral artery (SFA) in young recreationally
active men and women. Twenty-one men and twenty women arrived at the laboratory after
>3 h fast and were assigned randomly to SIT or Control (no training) groups. SFA diameter
and blood velocity (BV) were assessed using Doppler ultrasound and imaging before and
after 5 min of suprasystolic cuff inflation of the lower limb. Normalized flow mediated
dilation (FMD) was analyzed as the maximal ∆ in SFA diameter (%) ÷ shear rate (mean BV
x 8 ÷ SFA diameter: s-1) measured every 30 s for 5 min following cuff release. Percent FMD
(% FMD) was also calculated as the maximal ∆ in SFA diameter (%). Measures were
assessed before and following 6 weeks of SIT vs Control. After training, no changes in
baseline SFA diameter (Women: P=0.61; Men:P=0.33), peak shear rate (30 sec average) after
cuff release (Women: P=0.10; Men: P=0.22) or peak flow after cuff release (Women:
P=0.15; Men: P=0.50) were observed. However; in the women SIT decreased time to peak
dilation (Pre-=163±68 vs Post= 69±34 s; P=0.003), increased normalized FMD (SIT =
0.002±0.001 vs Control = 0.001±0.001 s-1; P= 0.02), and increased % FMD (SIT = 6.5±3.2
vs Control = 2.5±1.3 %; P= 0.04). There were no changes observed in the men. These data
suggest that SIT improved endothelial function in the women. The mechanisms responsible
as well as the reasons for the observed gender differences require further study.

Key words: Flow mediated dilation, Doppler ultrasound, blood velocity
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Chapter 1

2

1

Introduction
The cardiovascular system is composed of three components: the heart, the blood

vessels, and the blood and all three are important for cardiovascular health. In fact, blood
vessel properties, specifically the function of the most inward layer - the endothelium,
can be an early predictor of future cardiovascular health problems (Vita, 2005).
Furthermore, research has shown that endothelial function is reduced in people with
major risk factors for cardiovascular disease (CVD), such as high blood pressure,
smoking, and diabetes (Celermajer et al., 1992; Lloyd-Jones et al., 2010). Also, it is
known that the endothelial cell layer is vital to artery function, particularly the
vasodilatory response and likely this explains the association with CVD.
The properties of arteries, such as their ability to vasodilate, involve several
mechanisms. Shear stress (friction caused by blood flow against the vessel wall) or flowmediated dilation is one of these. Shear stress stimulates receptors on the endothelial
layer of arteries, which cause the release of a vasodilator substance, nitric oxide (NO).
NO is a gas that affects several target cells including smooth muscle cells, endothelial
cells, and inflammatory cells (Strijdom, Chamane, & Lochner, 2009) and it plays a major
role in cardiovascular cell signaling. In the myocardium, it is involved with contractility
and protects against ischemic injuries (Jones & Bolli, 2006). As such, NO is described as
an ubiquitous vasodilator that offers cardioprotective properties (Cooke & Dzau, 1997).
The flow mediated dilation (FMD) technique has been established as a means of
determining the endothelial function of arteries (nitric oxide mediated). Briefly, the FMD
technique uses Doppler ultrasound to examine the reactive hyperemic response of an
artery (via artery dilation) after artery blood flow has been occluded for a period of three
to five minutes. This is a valuable technique because it provides a link between NO
bioavailability and cardiovascular health (CH). Specifically, reduced bioavailability of
NO is associated with reduced CH and an increased prevalence of developing CVD
(Cooke & Dzau, 1997).
Currently, cardiovascular risk factors tend to occur at a much younger age than in
previous years (Lloyd-Jones et al., 2010; Roger et al., 2012) and a new initiative of the
American Heart Association (AHA) is focused on the prevention of various risk factors
(diabetes, hypertension) in the pediatric population (Lloyd-Jones et al., 2010; Roger et
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al., 2012). Some research even suggests that the offspring of parents with CVD are more
likely to have endothelial dysfunction, despite showing no other signs of cardiovascular
risk factors (Taddei et al., 1996). Thus, enhancing endothelial function in the younger
healthy population may be cardioprotective.
There is a great deal of evidence suggesting that low to moderate intensity
endurance exercise training can improve endothelium function (Green et al., 2004;
Maiorana et al., 2003; Moyna & Thompson, 2004; Walsh et al., 2003) especially in
cardiovascular at risk and/or diseased individuals. Further, regular exercise (light to
moderate intensity endurance exercise) decreases cardiovascular risk by 30% in
individuals with CVD (Thijssen et al., 2010). Conversely, it is less clear whether or not
exercise enhances endothelial function in a young healthy population (Clarkson et al.,
1999; Green et al., 2004; Maiorana et al., 2001). However, some suggest that matching
experimental groups based on age, sex, and body composition may help decrease
cofounding variables (Thijssen et al., 2010). Also, there is a dearth of literature about
exercise and endothelial function, particularly, in young healthy women. This may be in
part due to the added variability that hormonal fluctuation of the menstrual cycle adds to
endothelial function (Hayashi et al., 1995).
Interestingly, there is evidence in young healthy individuals to suggest that
repeated high intensity exercise, such as sprint interval training [SIT – four to six, 30 s
“all out” efforts separated by four min recovery between bouts, over several weeks
produces similar metabolic adaptations as traditional endurance training (Burgomaster et
al., 2007; Gibala et al., 2006). Moreover, a recent study found that SIT or endurance
training cause similar adaptations in endothelial function of the popliteal artery in young
healthy participants (Rakobowchuk et al., 2008). In addition, these investigators
speculated that if the sprint bouts were of longer duration endothelial function might be
enhanced further (Rakobowchuk et al., 2008). Certainly, the longer duration sprint bouts
could increase the amount of shear stress stimulus and facilitate a greater enhancement of
endothelial function but this proposed response has yet to be documented. Further,
additional research is needed to assess the effects of SIT on the endothelial function of
other conduit arteries (large blood vessels that provide a low resistant path for blood to
flow to organs and/or limbs). Importantly, SIT is very time efficient and may enhance
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endothelial function in young healthy individuals. If so, use of SIT could decrease the
early onset of cardiovascular risk factors and improve cardiovascular health. This would
be consistent with the AHA suggestion that improving cardiovascular health in the
younger population is likely a better way to decrease the prevalence of CVD into the
future, as opposed to focusing solely on managing and treating those who have already
developed CVD (Roger et al., 2012).
The aim of this thesis was to further understand the effect of a longer duration SIT
regimen (four – seven, 30 s to 45 s “ all out” effort bouts; three times per week over six
weeks) on superficial femoral artery endothelial function in young recreationally active
healthy men and women. It was hypothesized that the longer exercise bout (up to 7 x 45
s) SIT protocol would improve endothelial function of the superficial femoral artery.
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Chapter 2

6

2

Review of Literature

2.1

Vasculature
The cardiovascular system is composed of the heart, blood vessels, and the blood.

Specifically, the blood vessels (the vasculature) are composed of arteries, veins and
capillaries. Arteries carry blood away from the heart, whereas veins carry blood towards
the heart. With the exception of the pulmonary system, arteries transport oxygenated
blood and veins transport deoxygenated blood (Nicpon-Marieb, 2004).
The structures of arteries and veins have some similarities. For example, the
outermost layer of both is the tunica externa, the middle layer is the tunica media, and the
inner layer is the tunica intima. The tunica intima is composed of the endothelium and a
subendothelial layer. The endothelium layer makes contact with the blood. Arteries have
a much thicker tunica media than veins and, in addition to the three layers, have two
additional elastic layers called the internal and external lamina. The elastic components in
arteries, particularly in the aorta, are necessary because of the pressure exerted on the
walls when the blood is carried away from the heart (Nicpon-Marieb, 2004). As such, the
aorta is sometimes referred to as an elastic conduit artery. The role of conduit arteries
(superficial femoral artery, brachial artery, carotid artery, etc) is to provide a low
resistance path for blood to flow to organs and/or limbs (Greenwald, 2007).
2.2

Regulation of Blood Circulation
There are several factors, such as blood flow and resistance, which play a role in

the regulation of blood pressure and blood circulation. Blood flow is simply the volume
of blood flowing through a vessel in a given timeframe (ml•min-1). As blood flows
through the blood vessels, it exerts pressure on the vessel walls, expressed in millimeters
of mercury (mmHg), typically. Systolic pressure represents the highest pressure exerted
on the artery wall during the contraction phase of the cardiac cycle (systole) and diastolic
blood pressure is the lowest pressure exerted on the artery wall during the relaxation
phase (diastole). Resistance is another important component of blood circulation.
Resistance is the opposition to flow that is created as the blood travels through the blood
vessel; this creates friction against the vessel wall. Interestingly, most of the resistance is
found further away from the heart in the more peripheral arteries. Thus, resistance is
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commonly referred to as peripheral resistance. In 1864, Jean Baptiste Poiseuille
described the components that determine resistance (see equation below)
Resistance = 8 x viscosity x length x blood flow
π x radius4
where π = mathematical pi (~ 3.14)
Poiseuille’s Law (Pfitzner, 1976) states that resistance is affected by blood
viscosity (thickness), vessel diameter, and vessel length. The longer the vessel and the
greater the viscosity, the more resistance but both viscosity and vessel length remain
rather constant so often these are unimportant factors. In contrast, blood vessel diameter
is very dynamic; as the diameter decreases, friction or resistance increases. Further,
resistance varies inversely with the fourth power of the vessel radius. Therefore, a
doubling of vessel radius produces a large change (decrease) in resistance. Similarly, a
halving the arterial radius results is a sixteen-fold increase in resistance. The largest
changes in vessel diameter are observed in the smaller vessels, i.e., the arterioles.
Consequently, it is the smaller downstream vasculature that determines the resistance to
flow.
Hemodynamics, specifically describes the governing factors (blood pressure and
resistance) that define blood flow. Furthermore, there are principles that describe the
dynamics of blood flow. Ohm’s Law, first described by George Ohms in 1827, is a key
principle that governs flow of all fluids (Schagrin, 1963). Ohm’s law, as applied to blood,
states that blood flow is equal to the pressure differences between the arterial (high
pressure) and the venous (low) pressure divided by blood flow resistance (R).
Specifically, in arteries, the pressure gradient is the difference between any two points
along the vessel.
Ohm’s Law
Flow (ml • min-1) = change in pressure (ΔP)
Resistance (R)
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Lastly, arterial compliance and vascular conductance are elements that can change
in response to fluctuations in blood flow. Vascular conductance (VC) is the capacity of
blood to flow or the ability to transmit fluid. VC is equal to blood flow over change in
pressure (Calbet et al., 2004). Furthermore, as VC is increased, resistance is decreased
(see equation below).
VC (ml • min-1 • mmHg -1) = Flow (Q)
change in pressure (ΔP)
Rearranged from Ohm’s Law
R (mmHg • ml • min-1 ) = change in pressure (ΔP)
Flow (Q)
Arterial compliance is a mechanical property of arteries. Basically, it is the ability of the
arteries to stretch in response to changes in blood flow and/or pressure.
There are several important relationships that exist between blood flow, pressure,
and resistance. A change in one component (resistance) initiates changes in another
(pressure). Thus, it is clear that hemodynamics is an integrative process and that the
ability of the vascular system to maintain a balance between blood flow, pressure and
resistance is an important aspect of cardiovascular health.
2.3

Cardiovascular Health
Over the last decade, cardiovascular disease (CVD) among adults in North

America has been the leading cause of death and morbidity (Lloyd-Jones et al., 2010). As
a result, a large emphasis has been placed both on understanding how to decrease CVD
incidence as well as on ways to quantify the severity of CVD. A recent focus of the
American Heart Association (AHA) is to improve the cardiovascular health (CH) of the
entire population (Lloyd-Jones et al., 2010). A secondary focus of the AHA is to create
initiatives to combat the major risk factors (increased obesity, prevalence of both
hypertension and type 2 diabetes) in the pediatric population, because each is associated
with the development of CVD (Roger et al., 2011). This new trend/focus suggests that
improving CH in the younger population may help decrease the onset of cardiovascular
risk factors that lead to CVD.

9

Alterations in vascular properties, such as decreased arterial compliance (the
ability of the arteries to stretch in response to changes in blood flow and/or pressure) as
well as the ability to vasodilate, can be useful in identifying early signs of CVD
(O'Rourke & Hashimoto, 2008; Vita, 2005). Clearly, the endothelial layer in blood
vessels plays a key role in the ability of arteries to dilate or constrict. Overall, the goal of
improving CH is to reduce CVD via decreasing cardiovascular risk factors and to do so it
is important to understand that many of these risks originate in the endothelial layer of
the blood vessels.
2.4

The Endothelial Cell layer
The endothelium is the largest organ in the body and, as described above, is the

layer in the blood vessel structure that makes contact with the blood. One role of the
endothelium is to sense both mechanical and chemical stimuli associated with changes in
blood flow and blood pressure. Further, it is clear that the endothelial layer is quite
dynamic (Furchgott & Zawadzki, 1980). Seminal studies have described the role of the
endothelial cell layer in the vasculature in relation to changes in blood flow (Berdeaux et
al., 1994; Langille & O'Donnell, 1986; Pohl et al., 1986). These studies altered blood
flow in the arteries of animals with intact and denuded endothelium. The increase in
blood flow in the intact endothelium caused dilation, whereas in the denuded
endothelium there was constriction. These data suggest that increases in blood flow cause
an increase in diameter, which is both endothelial dependent and shear stress mediated
(Berdeaux et al., 1994; Langille & O'Donnell, 1986). Basically, as blood flows, friction
is created by the red blood cells making contact with the vessel wall; this friction is called
shear stress. Further, studies have manipulated shear stress to validate that changes in
arterial size were indeed shear stress mediated (Green et al., 2005; Pohl et al., 1986;
Rubanyi, Romero, & Vanhoutte, 1986).
Shear stress causes the endothelium to release agents that trigger the
inflammatory processes, regulate vasomotor function, and alter hemostasis (Endemann &
Schiffrin, 2004). NO and prostacycline are vasodilatory substances produced by the
endothelium. Specifically, NO is one of the most important endothelial derived relaxing
factors (Palmer, Ferrige, & Moncada, 1987) and decreased amounts of NO are associated
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with CVD (Creager et al., 1990). Clearly, the endothelial cell layer has a dynamic role in
vascular function. Thus, it is understandable that dysfunction or damage to the
endothelial cell layer has several implications for the onset of CVD.
Perhaps not surprisingly, hypertensive participants have a decreased ability for
forearm vasodilation (Panza et al., 1990). Further, CVD and several cardiovascular risk
factors are associated with a deficiency in vasodilation. For example, there are decreased
vasodilation responses in type 1 (Beckman et al., 2003) and type 2 diabetics (Rizzoni et
al., 2001), as well as in patients with coronary artery (Monnink et al., 2002) and/or
peripheral vascular disease (Park, Charbonneau, & Schiffrin, 2001). Furthermore, in 1996
Taddei and colleagues, demonstrated that the normotensive children of hypertensive
parents displayed endothelial dysfunction. Thus, not only is a decreased vasodilatory
response seen in the vasculature of those with CVD or cardiovascular risk factors, it may
precede the future development of CVD (Panza et al.,1990). Similarly, young adults and
children with a high risk of developing atherosclerosis, but who demonstrated no clinical
symptoms often have endothelial dysfunction (Celermajer et al., 1992). Other studies
have even linked endothelial dysfunction to a sedentary lifestyle (Green et al., 2003),
smoking (Oida et al.,2003), the metabolic syndrome, and dyslipidemia (Engler et al.,
2003) even in the absence of obvious cardiovascular disease.
This dysfunction or damage to the endothelial cell layer causes the vasodilatory
response to be hindered (particularly the response from rest to exercise). Clearly, the
inability of the arteries to dilate or constrict in response to changes in blood flow, due to
endothelial dysfunction, negatively affects vasomotor tone (the balance between
vasodilation and vasoconstriction). Additionally, vasodilation of the conduit arteries is
likely initiated at the microvasculature (via ascending vasodilation); so endothelial
function in the conduit may also be indicative of the function of the downstream
microvasculature (Ellis, Milkovich & Goldman, 2012; Moore, Rich, & Casellas, 1994;).
Interestingly, the inability to dilate in response to an increase in blood flow is a predictor
of the development of cardiovascular risk factors and/or disease and decreased
vasodilation is apparent in several forms of CVD so it is important to understand the
mechanisms associated with vasodilation.
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2.5

Vasodilatory Mechanisms
Vasomotor tone describes the variety of stimuli that govern the vasoconstriction

and vasodilation of blood vessels (Oluwole, McMIllen, & Sumpio, 1995). Blood flow is
determined by both vasomotor tone and changes in pressure gradient (Clifford, 2011).
Furthermore, there is a direct relationship between skeletal muscle blood flow and
metabolic demands (Clifford, 2011). Skeletal muscle contractions cause a rapid increase
in blood flow to the active musculature in order to increase oxygen delivery and to
remove the end products of accelerated metabolism. This is known as exercise
hyperemia. Initiation and maintenance of vasodilation in the blood vessels of skeletal
muscle associated with the exercise-induced hyperemia has five hypothesized
mechanisms. These mechanisms include mechanical factors, biochemical (sometimes
called conducted) hypothesis, red blood cell hypothesis, metabolic autoregulation, and
flow mediated/endothelial responses. All these mechanisms are essential to vasomotor
tone, which is integral in the control of local blood flow.
2.5.1

Mechanical Factors
The mechanical hypothesis of vasomotor control involves the muscle pump. The

muscle pump refers to when skeletal muscle acts as a mechanical force that creates
changes in the pressure gradient across the capillary bed. Specifically, contraction of
skeletal muscle causes it to shorten, which changes the dimensions (bulge) of the muscle.
This change in dimension squeezes the vasculature between/within the contracting
muscles, which moves the blood in veins towards the heart and reduces arterial in flow
changing the venous and arterial pressures (pressure gradient). Once the contraction is
released, there is a moment where there is a decreased amount of blood in the veins.
Thus, there is a rapid increase in blood flow from the arteries to the venous side upon
release of the muscle contraction. Furthermore, the increase (widening) in the pressure
gradient (arterial pressure to venous pressure) during muscle contraction and relaxation
causes an increase in blood flow (Laughlin, 1987). The onset of the exercise-induced
hyperemia response induced by the muscle pump occurs within one to two seconds of
exercise (Clifford & Hellsten, 2004). The muscle pump mechanism is a significant
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component associated with the rapid hyperemia that occurs from rest to exercise in the
skeletal muscle.
Another theorized mechanical aspect of vasodilation is myogenic autoregulation;
which is an active process of blood flow. It focuses on pressure differences inside and
outside of the blood vessel that cause changes in vasomotor tone. Decreased intraluminal
pressure stimulates mechanoreceptors that initiate a vasodilatory response (Clifford,
2011). Calcium ions (Ca++) play an important role in myogenic tone in both the smooth
muscle cells and the endothelial cells. Apparently, there is a competition for the control
of intracellular Ca++; in the endothelial cell increased Ca++ activates endothelial relaxing
factor NO (vasodilation), whereas in the smooth muscle cells it leads to vasoconstriction
(Moore, Rich, & Casellas, 1994; Nordlander, 1989). The time course of this myogenic
autoregulation vasodilatory response is approximately four to five seconds (Clifford,
2011). Studies have described the mechanical factors as the initial aspect of vasodilation.
However, there are other chemical mechanisms involved (Laughlin, 1987; Sheriff,
Rowell, & Scher, 1993).
2.5.2

Biochemical Hypothesis
The biochemical mechanisms of vasodilation are initiated by extracellular factors

but are driven primarily by changes in intracellular ions (calcium and potassium). This
response involves accetylcholine (Ach) which is a neurotransmitter found in both the
peripheral and central nervous system (Nicpon-Marieb, 2004). In the peripheral nervous
system, one of the functions of Ach is the activation of muscular contraction. When Ach
is released from a nerve cell (neuron) at the neuromuscular junction, it initiates skeletal
muscle contraction (Welsh & Segal, 1997). If Ach escapes (Ach spillover) from the
neuromuscular junction (NMJ), it may diffuse into the blood vessels and cause
vasodilation via both direct and indirect mechanisms (Welsh & Segal, 1997). Indirectly,
the Ach inhibits the release of norepinephrine (NE) from surrounding adrenergic neurons
and because NE is a vasoconstrictor the increase in Ach causes a decrease in
vasoconstriction. Directly, Ach interacts with both the smooth muscle cell (in the tunica
media) and endothelial cell layer of the blood vessels (Welsh & Segal, 1998). At the
intracellular level, Ach binds to muscarinic receptors (M3) on the cell membrane of the
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endothelial cell, which activates phospholipase C (PLC). PLC stimulates the conversion
of membrane phospholipid inositol biphosphate (PiP2) to inositol triphosphate (IP3) and
IP3 binds to the endoplasmic reticulum stimulating the release of endothelial Ca++
intracellularly (Clifford & Hellsten, 2004). This increase of calcium stimulates an
increase in nitric oxide synthase (NOS) which catalyzes the production of NO (Palmer,
Ferrige, & Moncada, 1987). NO then diffuses through the smooth muscle cell membrane
layer, where it increases guanylate cyclase (GC) which converts guanosine triphosphate
(GTP) to cyclic guanosine monophosphate (cGMP) (Strinden & Stellwagen, 1984).
cGMP activates the calcium - ATPase pump (Ca++ ATPase) to release Ca++ and the
release of Ca++ decreases Ca++ intracellularly (smooth muscle cell) causing relaxation
(vasodilation). The production of cGMP also inhibits the activation of myosin light chain
kinase (MLCK), a potent vasoconstrictor, via inhibition of PLC in the smooth muscle cell
(Boron & Boulpaep, 2003).
A secondary method by which Ach induces vasodilation is via hyperpolarization
of both smooth muscle cells and endothelial cells. Hyperpolarization is created when a
cell becomes more negative on the inside (intracellular) when compared to the outside
environment. The hyperpolarization creates an electrical gradient that can be passed
along arterial walls to either endothelial cells or smooth muscle cells (Clifford, 2011).
Hyperpolarization also initiates an onset of events that lead to calcium inhibition. Both
the creation of an electrical gradient and calcium inhibition causes vasodilation of the
smooth muscle cell (Welsh & Segal, 1998). The peak vasodilation response due to Ach is
reached in (eight to ten seconds) after the onset of exercise-induced hyperemia (Clifford
& Hellsten, 2004; Clifford, 2011).
2.5.3

Red Blood Cell Hypothesis
The third hypothesized vasodilatory mechanism involves the red blood cells

(RBC). When oxygen is released from a RBC, it also releases both adenosine triphoshate
(ATP) and NO (Bergfeld & Forrester, 1992; Stamler et al., 1997). When released ATP
binds to the purinergic receptor (P2Y) on the membrane of the endothelial cell it activates
PLC (Clifford, 2011). This causes the release of NO, which diffuses into smooth muscle
cell and leads to the relaxation of SMC, as previously described.
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2.5.4

Metabolic Autoregulation
The accumulation of metabolites (such as lactate, potassium ions, carbon dioxide,

and adenosine) from the muscles in the interstitial space can also lead to
hyperpolarization of smooth muscle cells (Clifford & Hellsten, 2004). Indirectly,
metabolite accumulation increases vasodilation by inhibiting or decreasing smooth
muscle cells sensitivity to norepinephrine (vasoconstrictor).
2.5.5

Flow Mediated/Endothelial Responses
The endothelial hypothesis involves shear stress and its effect on vasodilation.

Shear stress occurs in blood vessels when the red blood cells rub or create friction along
the endothelial layer. On the endothelial cell layer there are mechanoreceptors that sense
changes in mechanical pressure or distortion. These receptors on the endothelial layer are
called glycocalyx mechanoreceptors and are activated by blood flow induced (such as
exercise – induced hyperemia) shear stress (Pohl et al., 1986; Rubanyi, Romero, &
Vanhoutte, 1986). Apparently, there are two pathways that are initiated once the
mechanoreceptors are activated. The first pathway begins with phospholipase A2
(PLA2) catalyzing the production of arachidonic acid (Boron & Boulpaep, 2003).
Arachidonic acid is then catalyzed by cyclooxygenase into prostaglandins. One
particular prostaglandin, protacyclin I2, interacts with smooth muscle cells via coupling
with a G protein receptor on the smooth muscle cell membrane (Messina, Weiner, &
Kaley, 1977). This coupling signals the activation of adenylate cyclase converting ATP
to cyclic adenosine monophosphate (cAMP), reducing the influx of Ca++ via the calcium
channel, and activating Ca++ ATPase (removes calcium) in the smooth muscle cell. The
decrease in intracellular calcium leads to vasodilation.
The second pathway of the flow-mediated response begins with the G protein on
the endothelial cell membrane activating PLC. The mechanisms by which PLC activated
IP3 and increases Ca++ in the endothelial cell were described previously. However, the
details of endothelial NO production remains unclear. Increased Ca++ in the endothelial
cell increases NO synthase activity catalyzing the conversion of L-arginine and oxygen
(O2) into NO and L-citrulline (Palmer, Ferrige, & Moncada, 1987). NO can diffuse into
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the smooth muscle cell where it activates the conversion of GTP into cGMP (via
guanylate cyclase) inducing relaxation of the smooth muscle cell (vasodilation). As such,
the flow mediated vasodilatory response begins with a shear stress stimulus created by
exercise hyperemia (see Figure 1). However, there are other ways to generate the flow
mediate response in a resting state, particularly the NO flow-mediated response
(Celermajer et al., 1992).
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2.6
2.6.1

Methods to Assess Endothelial Function
Flow Mediation Dilation
As previously mentioned, there are several proposed mechanisms for blood vessel

dilation and there are techniques available to quantify these vasodilatory mechanisms.
One such technique is called flow mediated dilation (FMD). This technique was first
developed in 1992 by Celermajer and colleagues and is used typically to assess
endothelial cell layer function in blood vessels. It uses occlusion-induced hyperemia to
generate shear stress and noninvasive ultrasound to assess the FMD shear stress response
of the endothelium. The FMD technique has been correlated with artery (brachial,
carotid, femoral) endothelial function and several guidelines have been established to
standardize the technique (Harris et al., 2010; Thijssen et al., 2011). During the FMD test,
a suprasystolic cuff occlusion of the artery (brachial, carotid, femoral) causes a
circulatory arrest. After a standard amount of time (usually three to five minutes), which
is based on the artery size, the cuff is released and blood flow is measured. A five-minute
cuff occlusion of the superficial femoral artery has been shown to produce vasodilation
that is largely NO-dependent (Kooijman et al., 2008). The occlusion induced hyperemia
(or reactive hyperemia) increases shear stress along the vessel wall, which activates the
glycocalyx mechanoreceptors on the endothelial cell layer. This initiates the NO flow
mediated vasodilator process (previously described). After some experimental treatment,
this occlusion-induced vasodilation of the conduit artery can be compared to baseline
diameter of the artery and expressed as % FMD.
Of particular importance is the relationship between FMD and the endothelial
derived bioavailability of NO; the greater the % FMD (increase in diameter), as well as
the rate at which the vessel is able to increase its diameter in response to the reactive
hyperemia suggests increased bioavailability of NO (Doshi et al., 2001; Kooijman et al.,
2008; Thijssen et al., 2010a). Likewise, studies (Green, 2005) have found that FMD
reflects NO mediated endothelial function and that reduced bioavailability of endothelial
derived NO is associated with endothelial dysfunction, which, as mentioned, is an early
indication of atherosclerosis (Green et al., 2003). Thus, the measurement of FMD is
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important because it allows for the detection of the early onset of CV risk factors. Finally,
to maintain the reliability and reproducibility of FMD there are several precautions that
must be taken before testing.
2.7

Testing Procedures for FMD
There are several subject specific factors that are important to consider for the

accuracy of FMD testing including: medications (such as both tobacco and caffeine),
menstrual cycle, food intake, prior exercise, room temperature, and even time of day.
2.7.1

Medication
Medications can have both indirect and direct effects on blood vessels. So, it is

important that subjects refrain from taking any medication for greater than four half lives
of the drug (Corretti et al., 2002). Nonsteroidal anti-inflammatory drugs (NSAIDS)
should be avoided one to three days before, as well.
2.7.2

Tobacco Use
Tobacco use has many documented negative effects on cardiovascular health. Of

particular interest with FMD testing, is that smoking can reduce endothelial function
(Shimokawa et al., 1996). As such, cessation of smoking or exposure to second hand
smoking for greater than 12 hours prior FMD testing is recommended.
2.7.3

Caffeine
Caffeine decreases smooth muscle relaxation because of its ability to inhibit

soluble guanylate cyclase (Strinden & Stellwagen, 1984). Guanylate cyclase, as
previously described, is an enzyme involved in the cascade of events that lead to
vasodilation. Consequently, caffeine should be avoided for at least12 hours before FMD
testing.
2.7.4

Menstrual Cycle
Elevated endogenous estrogen and progesterone concentration have been

associated with increased endothelial NO synthase activity (Hayashi et al., 1995). When
testing premenopausal women, testing should be done at the same time of the menstrual
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cycle for all participants. Furthermore, when testing for sex differences, all
premenopausal women participants should be tested during the early follicular phase of
the menstrual (day 1 to day 7 of the menstrual cycle), due to the low circulating estrogen
and progesterone concentrations at this time (Hashimoto et al., 1995).
2.7.5

Food Intake
Studies have shown that consuming a high fat or high carbohydrate meal prior to

testing can attenuate the FMD response in participants (Padilla et al., 2006). Further, it
has been suggested that post meal hypertriglyderidemia leads to acute endothelial
dysfunction (Bae et al., 2001). Consequently, the most common procedure for FMD
measurement is to test under fasting conditions of > three hours.
2.7.6

Familiarization
For accurate FMD testing, participants should be relaxed and familiar to the

testing protocol. All participants should be introduced to the testing procedure on a
separate day, prior to the FMD testing. On the testing day each participant should be
given >20 minutes of quiet resting time in the testing position (supine, prone) in a
temperature controlled room (22 to 24 degrees Celsius). These precautions are necessary
to decrease the possibility of sympathetic or orthostatic responses, which could affect the
baseline diameter measurements of the artery (Thijssen et al., 2011).
2.7.7

Time of Day and Exercise
For valid and repeatable FMD testing, when assessing endothelial function

changes in a research study design, it is also important to perform FMD testing for each
participant at the same time of day due to diurnal effects on FMD measurements
(Jarvisalo et al., 2006). Lastly, as previously mentioned, acute exercise induced
hyperemia causes vasodilation and has been shown to improve FMD measures in
participants (Clarkson et al., 1999). As such, there should be at least 12 hours of
abstinence from exercise prior to FMD testing.
When all these considerations are considered and, assuming accurate measures of
artery diameter and blood velocity, FMD can be an accurate and reproducible test
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(Celermajer et al., 1992; Ghiadoni et al., 2012; Harris et al., 2010; Thijssen et al., 2011).
Typically, artery diameter and blood velocity are determined using Doppler ultrasound.
2.8

Ultrasound
Doppler ultrasound and Brightness mode (B-mode) ultrasound imaging can be

used to assess changes in blood flow, blood velocity, blood vessel images, and shear
stress. Briefly, an ultrasound transducer contains piezoelectric crystals that when
connected to electrical sources transmit high frequency sound waves (Ultrasound:
Frequency greater than 20,000 Hertz) (Fronek, 1989). The sound waves reflect off
materials in proportion to the materials density. Ultrasound is based on the strength of
the signal that is returned to the transducer. When ultrasound is reflected off moving red
blood cells, the difference between the emitted frequency and the frequency that is
reflected back to the transducer is called the Doppler shift (Kremkau, 1990). The Doppler
shift allows an image or blood velocity waveform to be constructed and then displayed
onto a screen. Both the artery image and blood velocity waveform are crucial aspects of
FMD.
During FMD testing arterial diameter is assessed with B-mode ultrasound
imaging. Doppler ultrasound is used to assess the blood velocity waveform of the artery.
To achieve the most accurate representation of the Doppler shift, the angle of insonation
should be 60 degrees for Doppler ultrasound and 90 degrees for B mode image
ultrasound (Fronek, 1989). Further, when measuring the artery diameter change from the
cuff induced reactive hyperemia, the placement of the suprasystolic cuff should be distal
to the transducer (Doshi et al., 2001) because studies have shown that the placement of
the cuff distal to the transducer is likely to produce a FMD response that is NO dependent
(Doshi et al., 2001). Finally, when doing a repeated measures study, physical anatomical
landmarks such as the anterior iliac crest, should be used to keep the location of the artery
measures constant for both the pre- and post measures (Thijssen et al., 2011). This is
critical because as you travel along an artery, the blood vessel diameter can change. So, if
artery diameter measures of the superficial femoral artery are taken 10 centimeters below
the iliac crest for the FMD pre-measures and then for the FMD post measures, the
superficial femoral artery diameter is taken say 20 centimeters below the iliac crest, any
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changes in the SFA diameter may be caused by the location rather than the study
intervention.
2.9

Exercise as an Intervention
With recent standardization and precision of the FMD methodology (Harris et al.,

, 2010; Pyke & Tschakovsky, 2005; Thijssen et al., 2011) FMD has been used widely in
studies to examine the various interventions that can alter vascular function and
cardiovascular risk factors (Hopkins et al., 2009; Kawano et al., 1997; Kawano et al.,
2009; Liuni et al., 2010). One intervention of particular interest is exercise. Recently, the
American College of Sport Medicine (ASCM) has released a new initiative; “Exercise is
Medicine” (Garber et al., 2011) in part because exercise is associated with a 30%
reduction in cardiovascular risk (Thijssen et al., 2010) and is integral in the maintenance
of good CH (Haskell et al., 2007).
Landmark studies (Langille & O'Donnell, 1986; Pohl et al.,1986) have established
that increases in blood flow cause an increase in arterial diameter, which is endothelial
dependent and shear stress mediated. Hambrecht and colleagues (2003) provided further
evidence that increases in blood flow via endurance exercise training (four weeks)
increased shear stress, which increased artery diameter (via %FMD) in the exercise group
when compared to the non-exercise group. Furthermore, they also extracted a portion of
the artery and were able to measure an increased NO synthase protein expression and
phosphorylation of endothelial NOS (eNOS) in the exercise trained group vs the nonexercise group. This, as well as several other studies have established that endurance
exercise training improves endothelial function in vivo by increasing NO synthase
protein expression and the phosphorylation of its enzyme in cardiovascular disease and/or
at risk individuals (Berdeaux et al., 1994; Hambrecht et al., 2003; Langille & O'Donnell,
1986; Laughlin & Roseguini, 2008; Thijssen et al., 2008). These effects are mediated by
increased shear stress (Tinken et al., 2010) and ultimately; result in enhanced NO
bioavailability in the endothelial cell layer with training. However, the findings for
endothelial adaptations with endurance exercise training in healthy asymptomatic
individuals are not as clear.
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Maiorana and colleagues conducted two identical training studies investigating
the effects of endurance exercise training on endothelial function in healthy (study 1) and
heart failure (study 2) participants and found contradictory results (Maiorana, O'Driscoll,
Cheetham et al., 2001; Maiorana, O'Driscoll, Dembo et al., 2001). The heart failure
participants showed an increase in endothelial function while there was no change in
endothelial function in the healthy participants. Similarly, other studies have reported no
change in endothelial function with endurance exercise training (Green et al., 2004;
Maiorana et al., 2003). Particularly, interesting is one study by Bergholm and colleagues
(1999) that revealed that 12 weeks of higher intensity endurance training (70 to 80% of
VO2max) increased oxidative stress, which could affect endothelial function adversely.
However, Goto and colleagues (2003) reported that despite an increase in oxidative
stress, 12 weeks of higher intensity endurance training (75% of VO2max) did not decrease
endothelial function. To the contrary, some studies have shown endurance and resistance
training exercise-induced improvements in vascular function in healthy participants
(Clarkson et al., 1999; Rakobowchuk et al., 2005). Thus, there continues to be disparity
in the literature about the benefits of exercise training on endothelial vascular function in
healthy subjects.
Thijssen and colleagues (2001) suggest that some of the inconsistencies that exist
with exercise training and vascular function in healthy subjects may be due to training
modalities, exercise intensity, and baseline vascular function. Most studies have used
aerobic (endurance) types of exercise at low to moderate intensities as the training
stimulus for vascular function adaptations. However, current guidelines state that both
the general health and aerobic fitness benefits of exercise are likely exercise intensity
driven. Shorter, but more intense exercise is better at eliciting the health benefits
associated with regular exercise (Tremblay et al., 2011). Similarly, there is evidence to
suggest that repeated high intensity exercise, such as sprint interval training (Gibala et al.,
2006) produces similar metabolic adaptations (Burgomaster et al., 2007), exercise
performance and body fat losses (MacPherson et al, 2011), as those seen with traditional
endurance training. In contrast, with the exception of one study, little is known about the
effects of sprint interval exercise training on endothelial function (Rakobowchuk et al.,
2008).
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Typically, SIT involves ~four-eight repeated “all out” effort sprints (cycling,
running) separated by four min recovery periods of rest or low intensity exercise. The
“all out” effort sprints can vary in duration, but the most common duration is 30 s
(Burgomaster et al., 2005; Hazell et al., 2010; MacPherson et al., 2011) . Clearly, SIT is
a time efficient mode of exercise. Importantly, despite, the time efficiency and
beneficial metabolic/performance/body fat loss adaptations of SIT when compared to
endurance training, there are few studies that have focused on the vascular adaptations of
SIT, particularly endothelial function.
Recently, endothelial function of the popliteal artery, a common site of
atherosclerosis, (Debasso et al., 2004) was evaluated following both endurance training
and SIT (cycling) (Rakobowchuk et al., 2008; Rakobowchuk et al., 2009). A significant
increase in endothelial function in both the endurance training and SIT group was
observed and it was suggested that performing the same training study on participants
with decreased vascular function might elicit an even greater adaptation. Rakobowchuk
and colleagues also evaluated carotid artery distensibility (a measure of cardiac
performance/central adaptation) in both the SIT and endurance training groups and found
no improvements in central distensibility. They suggested that a longer bout duration
training stimuli may be required to elicit central adaptations. Additionally, MacPherson
and colleagues, compared six weeks of SIT (running) to endurance training in young men
and found that both groups improved their VO2max after training. However, the
improvements in VO2max in the SIT group were due primarily to an increase in arterialmixed venous O2 (a - vO2) difference (training adaptation at the muscle/ peripheral
adaptation). Whereas, the improvements in VO2max in the endurance training group were
due primarily to an increase in maximal cardiac output (increase in heart stroke
volume/central adaptation). Thus, both Rakobowchuk and colleagues and MacPherson
and colleagues’ studies revealed that four to six, 30 s sprints (three times per week) over
six weeks are not sufficient to elicit central adaptations. As such, increasing the duration
of each sprint bout as well as the number of sprint bouts may lead to a central adaptation
that would increase shear stress and mediate a greater improvement in endothelial
function.
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Interestingly, like the popliteal, recent studies suggest that the superficial femoral
artery may also be a site for the early onset of atherosclerosis (McDermott et al., 2011).
Further, unlike the popliteal artery, the superficial femoral artery is a larger artery that
supplies blood to both the thigh and lower leg. This difference in arterial size may
produce different inward vascular structure remodeling with interventions (Thijssen et al.,
2008). Furthermore, unlike the popliteal artery, the superficial femoral artery has been
researched and established as a conduit artery that is NO dependent in nature and
appropriate to evaluated endothelial function via the FMD technique (Kooijman et al.,
2008; Thijssen et al., 2011). Consequently, to better understand the endothelial function
adaptations of the lower limb conduit arteries to SIT, examinations of various lower limb
arteries are necessary.
2.10

Summary, Purpose and Hypothesis
The function of the blood vessels, in particular the endothelial cell layer, is an

important component of cardiovascular health. The FMD technique is a reproducible
means to quantify NO mediated endothelial function (Ghiadoni et al., 2012; Thijssen et
al., 2011). Various interventions, including exercise training (primarily endurance) have
been used to improve endothelial function in different populations. However, with the
exception of a few recent studies on high intensity exercise, the most common form of
exercise used to increase endothelial function have been low to moderate intensity
(endurance type) exercise.
The aim of this study was to investigate how a longer duration run SIT program
(four–seven, 30 s to 45 s “all out” effort bouts; three times per week over six weeks)
affects both vascular function (endothelial function) and hemodynamics of the superficial
femoral artery in a young healthy population. It was hypothesized that the longer
exercise bout (up to 7 x 45 s) SIT protocol would improve endothelial function of the
superficial femoral artery, quantified via an increased response to reactive hyperaemia
(Flow mediated dilation).
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3

Methods

3.1

Participants
Participants (n = 41) volunteered for the study. Each was given a survey to assess

his or her Cardiovascular Health (CH; see Appendix A) and those with cardiovascular
risk factors or diabetes were excluded from the study. All were recreationally active (not
engaged in an organized exercise program more than two sessions per week) and were
deemed able to participate in physical activity via the Physical Activity Readiness
Questionnaire (PAR-Q) (Thomas et al., 1992). The project was approved by the Health
Science Research Ethics Board at the University of Western Ontario and both the
experimental procedures and any risks were explained fully prior to the any data
collection. All participants provided written, informed consent.
3.1.1

Familiarization
All participants completed a familiarization session that included all experimental

procedures prior to the baseline testing to minimize any learning effect on the measures.
3.2

Baseline Test
The baseline testing took place during a one-hour visit to the Neurovascular

Research Lab (NVRL). Most participants were pre- and post tested at the same time of
day (within 3 hours). Sixteen participants were measured during the morning and 25
during the afternoon. Changes in schedules created inconsistencies in the pre- and post
testing for three participants. They were tested within 4, 5 and 5 hours, respectively.
All measures were taken following a ≥3 h fast, ≥12 h abstinence from caffeine,
alcohol, nicotine or vigorous physical activity in a temperature-controlled (23-24 °C)
room. Female participants were measured during the early follicular phase of the
menstrual cycle. Unfortunately, this necessitated some variability in time following the
last training session for the post testing measures. For example, some female participants
were tested the day after their last sprint interval exercise bout (Early: 1-4 days after last
exercise bout) and others were tested up to two weeks after the last sprint interval
exercise bout (Late: 5-14 days after last exercise bout). Lastly, due to injury or irregular
menstrual cycle duration, two participants’ post testing measures were done before (one
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week prior) the end of the six weeks of sprint interval training. The aforementioned
methods for baseline testing were based on previous research (Thijssen et al., 2011).
3.2.1

Cardiac Cycle and Resting Blood Pressure
During 20 min of supine rest each participant’s cardiac cycle was monitored with

a standard two–lead (three electrodes) electrocardiogram (ECG) sampled at 1,000 Hz via
a computer-based data acquisition and analysis system (PowerLab; ADInstruments).
Blood pressure was assessed continuously from the middle finger of the right hand using
the volume clamp technique (Finometer; Finapres Medical Systems BV). The Finometer
blood pressure values were validated via three manual sphygmomanometer measures
with a single investigator. The finger arterial pressure values collected from the
Finometer were integrated into the non-linear three-element model or inverse antiresonance model, and corrected for differences in waveforms between finger-to-brachial
pressure to estimate mean arterial pressure (MAP) (Zamir et al., 2007). Both cardiac
cycle and blood pressure were measured continuously throughout the entire hour testing
session. MAP and cardiac cycle data was collected via a computer-based data acquisition
and analysis system (PowerLab; ADInstruments).
3.2.2

Flow Mediated Dilation (FMD) and Arterial Characteristics
The assessment of vascular function and the hemodynamics of the superficial

femoral artery (SFA) were achieved with the flow-mediated dilation (FMD) technique
(see figure 2). SFA images and blood velocity (BV) were assessed with ultrasound
imaging (4 MHz Doppler ultrasound, 10 MHz Doppler ultrasound imaging, GE Vivid 7)
before and after 5 min of suprasystolic cuff inflation of the lower leg (Thijssen et al.,
2011). Specifically, the cuff was positioned over the tibial tuberosity of the right leg and
inflated to ≥200 mmHg to occlude the SFA (Doshi et al., 2001). The entire FMD
procedure included 12 minutes of SFA BV measurements (2 min of baseline, 5 min of
cuff inflation and 5 min after cuff release). The angle of insonation was held at ≤60° for
all participants. SFA images were taken at baseline (before cuff inflation), as well as
every 30 s (up to 5 min) following cuff release. All SFA images were taken with the 10
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MHz Doppler imaging probe positioned 30-35 cm from the iliac crest. Again the
Powerlab system was used for acquisition and analysis of the SFA blood velocity.
Figure 2 : Flow Mediated Dilation (FMD): Protocol
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3.2.3

Sprint Interval Exercise Training (SIT)
The six weeks of SIT consisted of three sessions per week. Sessions were

separated by at least one day. Participants exercised in a temperature controlled (21 °C)
room. All sprint bouts were completed on a manually driven treadmill (Desmo Pro,
Woodway®, Wisconsin, USA), so that the participant was the power source for the
running belt. The training protocol was as follows:
Day

*Week 1

Week 2

Week 3

Week 4

Week 5

Week 6

1

4 reps x

4 reps x

4 reps x

5 reps x

6 reps x

7 reps x

30 s

35 s

45 s

45 s

45 s

45 s

4 reps x

4 reps x

4 reps x

5 reps x

6 reps x

7 reps x

30 s

40 s

45 s

45 s

45 s

45 s

4 reps x

4 reps x

4 reps x

5 reps x

6 reps x

7 reps x

35 s

40 s

45 s

45 s

45 s

45 s

2

3

* All sprint bouts were separated by four minutes of rest
* Training was adapted from previous research (Macpherson et al.,, 2011)
3.2.4

Body Composition
Body composition was assessed in the Exercise Nutrition Research Lab (ENRL)

via whole body densitometry using air displacement plethysmography (Bod Pod®, Life
Measurements, Concord, CA). All testing procedures were in agreement with the
manufacturer’s instructions as detailed in the manual and thoracic gas volume was
estimated for all participants using the predictive equation of the Bod Pod® software.
The system software was used to complete all calculations.
3.3

SFA Diameter and Blood Flow Data Analysis
The terms blood flow, blood velocity, shear stress and shear rate are commonly

used to describe blood vessel waveforms and the reactive hyperemia response of FMD
and so, it is important that the definition of these terms are clear. As previously
described, blood flow (ml•min-1) is the volume of blood that is circulating per unit of
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time. Whereas, blood velocity (cm•s-1) is the distance that blood is travelling with respect
to time. However, flow can be related to velocity by the following equation:
Flow = blood velocity x vessel cross-sectional area;
where, cross-sectional area of the vessel = π x radius2
Shear stress is the friction that is created as the red blood cells rub or move along
the endothelial cell layer of blood vessels. Shear stress takes into account the changes in
blood viscosity, whereas, shear rate assumes that blood viscosity does not significantly
change from person to person. Shear rate and shear stress differ in how they are
calculated:
Shear rate= 8 x blood velocity / diameter of blood vessel
Shear stress= 8 x viscosity x blood velocity/ diameter of blood vessel
Recent studies have shown that the addition of blood viscosity measures in the
shear stress equation, does not significantly impact on the FMD outcome measures
(Padilla et al., 2008) so for the current study blood viscosity was not measured.
Digital calipers were used to obtain the luminal diameters of the SFA. SFA
diameters were assessed as the average of three digital caliper measurements. The same
investigator measured all SFA diameters. All SFA diameters were determined at end
diastole of the cardiac cycle. Diastolic arterial diameters are a better representation of the
actual size of the artery because at rest, diastole is considered to be 2/3 of the cardiac
cycle vs systole which is 1/3 (Radegran, 1997). Peak SFA diameter and time to peak
(TTP) SFA diameter were also recorded. TTP diameter was calculated as the time in
seconds (with a 30 s resolution), from cuff release to when peak SFA diameter occurred
(Thijssen et al., 2011). The peak SFA diameter after cuff release when compared to the
baseline SFA diameter was used to express relative change or percent (%) FMD
(Celermajer et al., 1992). The equation used for % FMD is as follows:
% FMD= (peak SFA diameter - baseline SFA diameter/baseline SFA diameter) x 100
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To further quantify the reactive hyperemia associated with FMD, SFA blood flow
(BF) and shear rate (SR) were calculated. In order to avoid underestimating the SR
stimulus, SR was averaged over 3 (30 s resolution of SFA diameters were used) and 30 s
and calculated as follows (Harris et al.,, 2010; Pyke & Tschakovsky, 2007):
BF (ml•min-1) = π x r2 x SFA BV x 60;
where, r = radius
Shear rate : SR (s-1) = 8 x SFA BV/SFA diameter
It has been suggested that a specific time frame interval be used for SR area under
the curve (AUC). The time interval from time of cuff release to peak artery dilation is
likely the best time interval to use to accurately quantify the SR stimulus because the SR
created by the five minute cuff inflation is the stimulus that drives the dilation of the
artery (Pyke & Tschakovsky, 2005). So to quantify the FMD stimulus, SR data were
plotted vs time and using the area under the curve (AUC; trapezoid method) of 1) the SR
from 15 to 45 s after cuff release and 2) the SR from cuff release to peak SFA diameter
(Thijssen et al., 2011).
SR area under the curve =
(0.5) x [(t1 + t5) / 2] + t2 + t3 + t4 (Pyke & Tschakovsky, 2007)
Where t = the shear rate at 30 s time intervals
Further, the amount of SR stimulus that is induced by the five minute
suprasystolic cuff inflation with FMD can vary between subjects (Pyke & Tschakovsky,
2005; Pyke & Tschakovsky, 2007). So, in order to standardize the FMD for the differing
amounts of SR stimulus for each subject, FMD measurements were normalized as
follows:
Normalized FMD:
Peak = % FMD/ SR
AUC 1= % FMD/ SR AUC (15 - 45 s)
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AUC 2= % FMD/ SR AUC (cuff release - SFA peak diameter)
3.4

Statistical Analyses
Statistical analyses were performed using Sigma Stat for Windows (version 3.5).

Statistics were calculated separately for men and women. A two way ANOVA was used
to test significance between the groups and time points, with a post-hoc Tukey test, where
necessary. The level of significance was set at p < 0.05. Data are presented as means ±
standard deviation. Due to limitations with the VO2peak testing equipment (used to
determine if SIT was an effective training regimen) and adherence to the training (see
results and discussion), a one-way ANOVA was done on the VO2peak results of the
treatment group to determine if a treatment effect was evident.
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4

Results

4.1

Participant Characteristics

4.1.1

Women
Twenty women participated in the study. Fourteen women were randomly

assigned to the SIT group and six to the control group. All anthropometric measures
were similar between groups at baseline (Table 1).
Table 1 Anthropometric measures SIT vs control.
Women (n = 20)
SIT (n = 14) Control (n = 6)
Age (y)
24 ± 4
23 ± 3
Height (cm)
165 ± 5
164 ± 5
62.0 ± 15
Mass (kg)
65.3 ± 7.2
Lean mass (kg) 47.0 ± 3.4
47.8 ± 5.6
Fat mass (kg)
18.3 ± 6.2
14.0 ± 10
% Fat (%)
27.5 ± 6.6
20.8 ± 10
Values are means±SD
4.2
4.2.1

Training
VO2peak of Female Participants
Two women in the SIT group and two women in the control group were excluded

from the VO2peak measures results due to nonadherence to training, injury, and
malfunction of testing equipment, respectively.
4.2.2

VO2peak
There was no significant group by time interaction in VO2peak (p = 0.28), (SIT:

pre-, 45.3 ± 4.4: post 48.1 ± 3.8; Control: pre-, 51.5 ± 4.1: post, 51.6 ± 3.1 mlkg-1min-1;
mean ± SD). There was a main effect for group (p = 0.03) but no main effect of time (p =
0.25) perhaps indicating that the SIT group’s VO2peak (46.7 ± 4.2 mlkg-1min-1) was
significantly lower than the control group (51.6 ± 3.4 mlkg-1min-1) or that there was an
increase with SIT. An independent analysis of groups (one way ANOVA) revealed a
significant increase in VO2peak (p = 0.05) within the SIT group (pre- to post).
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4.3

Baseline Mean Arterial Pressure (MAP)
There was no significant group by time interaction (p = 0.96) in baseline resting

(supine position) MAP (SIT: pre-, 85.0 ± 6.4: post, 85 ± 6.1; Control: pre-, 83.0 ± 6.3:
post, 84.0 ± 8.4 mmHg). Further, there was no main effect for group (p = 0.48) or time
(p = 0.80).
4.4

Baseline Blood Flow Measures
There was no significant group by time interaction in baseline blood flow (p =

0.86) or baseline shear rate (p = 0.73), (blood flow SIT: pre-, 60.0 ± 27.0: post 53.0 ±
17.5; Control: pre-, 48.0 ± 15.2: post, 55.9 ± 29.0 mlmin-1), (Shear rate SIT: pre-, 50.0 ±
23.3: post, 60.3 ± 27.3: Control: pre-, 41.0 ± 17.3: post, 47.9 ± 32.2 s-1;). There was no
main effect for group (blood flow: p = 0.27), (shear rate: p = 0.32) or time (blood flow: p
= 0.29), (shear rate: p = 0.18).
4.5

Baseline Diameter
Likewise, there was no significant group by time interaction in baseline SFA

diameter (p = 0.21) between groups (SIT: pre-, 5.97 ± 0.50: post, 5.82 ± 0.56; Control:
pre-, 5.96 ± 0.51: post, 6.03 ± 0.63 mm). There was no main effect for group (p = 0.92)
or time (p = 0.61).
4.6

Peak Blood Flow Measures (three second average)
There was no significant group by time interaction in the three second average

peak blood flow (p = 0.44) or the three second average peak shear rate (p = 0.11) (Blood
flow SIT: pre-, 647 ± 200: post 849 ± 211; Control: pre-, 713 ± 250: post, 801 ± 313
mlmin-1), (Shear rate SIT: pre-, 534 ± 125: post, 749 ± 219: Control: pre-, 575 ± 207:
post, 600± 85 s-1). There was no main effect for group (blood flow: p = 0.97), (shear rate:
p = 0.40). However, there was a main effect of time (blood flow: p = 0.03), (shear rate: p
= 0.05). Likely, the increase in peak shear rate and peak blood flow over time was driven
by the SIT group as peak shear rate increased by 215 s-1 in SIT group vs 25 s-1 in the
control group. Further, the peak blood flow in the SIT group increased by 202 mlmin-1
vs 88 mlmin-1 in the control group.
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4.7

Peak blood flow measures (30 second average)
There was no significant group by time interaction in the 30 second average peak

blood flow (p = 0.16) or the 30 second average shear rate (p = 0.36), (Blood flow SIT:
pre-, 477 ± 181: post 643 ± 176; Control: pre-, 541 ± 217: post, 543 ± 190 mlmin-1),
(Shear rate SIT: pre-, 370 ± 111: post, 499 ± 159: Control: pre-, 407 ± 146: post, 445 ±
131 s-1). There was no main effect for group (blood flow: p = 0.80), (shear rate: p = 0.86)
or time (blood flow: p = 0.15), (shear rate: p = 0.11).
4.8

Peak Diameter
Likewise, there was no significant group by time interaction (p = 0.58) in peak

SFA diameter (SIT: pre-, 6.22 ± 0.50: post, 6.20 ± 0.54; Control: pre-, 6.30 ± 0.60: post,
6.18 ± 0.66 mm). There was no main effect for group (p = 0.92) or time (p = 0.47).
4.9

Flow Mediated Dilation

4.9.1

FMD
There was a significant group by time interaction in %FMD (p =0.03) between

groups. A Tukey’s HSD poc hoc test revealed a significantly greater (p = 0.04) %FMD in
the SIT group (post, 6.5 ± 3.2 %) vs control (2.5 ± 1.3%) (Fig 3). There was no main
effect for training status (p = 0.22) or time (p = 0.56).
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Figure 3. FMD before and after 6 weeks of SIT vs control. Values are means±SD (n =
20). * Significantly different post training values between groups (p<0.05)
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4.9.2

FMD: Peak (normalized)
There was no significant group by time interaction (p = 0.10) in %FMD

normalized for peak shear rate (SIT: pre-, 0.011± 0.008: post, 0.014 ± 0.005; Control:
pre-, 0.011 ± 0.010: post, 0.006 ± 0.003 a u). There was no main effect for training status
(p = 0.19) or time (p = 0.56).
4.9.3

FMD: AUC (normalized)
There was a significant group by time interaction (p = 0.03) in % FMD

normalized for the shear rate area under the curve (AUC) from cuff release to peak
dilation between groups. A Tukey’s HSD poc hoc test revealed a significantly greater (p
= 0.02) %FMD:AUC for the SIT group (0.002 ± 0.001 a u) vs the control group (0.001 ±
0.001 a u) (Fig 4). There was also a significant (p = 0.01) increase in %FMD:AUC, post
training (pre-, 0.001 ± 0.001: post, 0.002 ± 0.001) in the SIT group. There was no main
effect for training status (p = 0.22) or time (p = 0.56).

Figure 4. FMD:AUC before and after 6 weeks of SIT vs control. Values are means±SD
(n = 20). * Significantly different (p<0.05).
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4.9.4

FMD: AUC15-45 s (Normalized)
There was no significant group by time interaction (p = 0.34) in %FMD

normalized for the shear rate area under the curve (AUC) from 15 second after cuff
release to 45 seconds (SIT: pre-, 0.003 ± 0.003: post, 0.004 ± 0.002; Control: pre-, 0.003
± 0.003: post, 0.002 ± 0.001 a u ). There was no main effect for training status (p = 0.28)
or time (p = 0.50).
4.9.5

Time to Peak Dilation
There was a significant group by time interaction (p = 0.02) in time to peak

dilation (TTPD) after cuff release. A Tukey’s HSD poc hoc test revealed a significant
decrease (p = 0.03) in TTPD in the SIT group (post, 69 ± 34 s) when compared to pre(pre-, 163 ± 68 s) training (Fig 5). There was no main effect for training status (p = 0.80)
but there was a main effect of time (p = 0.003).
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Figure 5. TTPD before and after 6 weeks of SIT vs control. Values are means±SD (n =
20). * Significantly different (p<0.05).
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4.9.6

Area under the Shear Rate Curve (AUCSR)
There was no significant group by time interaction in area under the shear rate

curve (AUCSR) (p = 0.84) for AUCSR (SIT: pre-, 4021.5 ± 1382.0: post, 3663.7 ± 1548.4;
Control: pre-, 3471.6 ± 1622.5: post, 3279.5 ± 1303.6 s-1). There was no main effect for
training status (p = 0.45) or time (p = 0.49)
4.10
4.10.1

Participant Characteristics
Men
Twenty- one men participated in the study. Fifteen men were randomly assigned

to the SIT group and six were to the control group. All anthropometric values were
similar at baseline (Table 2).
Table 2 : Anthropometric measures of SIT vs control. Values are means±SD.
Men (n = 21)
SIT (n = 15) Control (n = 6)
Age (y)
22 ± 5.0
24 ± 1.0
Height (cm)
178 ± 8.0
175 ± 6.0
77.5 ± 7.7
Mass (kg)
78.8 ± 10.7
Lean mass (kg) 67.0 ± 7.4
65.8 ± 8.8
Fat mass (kg)
11.7 ± 6.4
11.7 ± 3.3
% Fat (%)
14.4 ± 6.6
15.3 ± 5.1
4.11
4.11.1

Training
VO2peak
There was a significant group by time interaction (p = 0.02) in VO2peak. A

Tukey’s HSD poc hoc test revealed a significantly greater (p = 0.039) VO2peak with SIT
(pre-, 54.4 ± 6.8 vs post, 56.8 ± 6.7 mlkg-1min-1) (Fig 6). There was no main effect for
group (p = 0.83) or time (p = 0.80).
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Figure 6. VO2peak before and after 6 weeks of SIT vs no training in men. Values are
means±SD (n =20). *Significantly different (p < 0.05)
4.12

Baseline Mean Arterial Pressure (MAP)
There was no significant group by time interaction (p = 0.23) in resting (supine

position) baseline MAP (SIT: pre-, 81 ± 10: post, 83 ± 8; Control: pre-, 86 ± 9: post, 84 ±
12 mmHg). There was no main effect for group (p = 0.48) or time (p = 0.80).
4.13

Baseline Blood Flow Measures
There was no significant group by time interaction in baseline blood flow (p =

0.19) or baseline shear rate (p = 0.15) (Blood flow SIT: pre-, 77.8 ± 30: post 103 ± 41;
Control: pre-, 84 ± 35.: post, 88 ± 30 mlmin-1), (Shear rate SIT: pre-, 41 ± 18: post, 58 ±
26: Control: pre-, 47 ± 22: post, 49 ± 18 s-1; mean ± SD). There was no main effect for
group (blood flow: p = 0.74), (shear rate: p = 0.88) or time (blood flow: p = 0.08), (shear
rate: p = 0.09).
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4.14

Baseline Diameter
Likewise, there was no significant group by time interaction (p = 0.33) in baseline

SFA diameter (SIT: pre-, 6.90 ± 0.57: post, 6.80 ± 0.45; Control: pre-, 6.74 ± 0.33: post,
6.79 ± 0.44 mm). There was no main effect for group (p = 0.69) or time (p = 0.71).
4.15

Peak Blood Flow Measures (three second average)
There was no significant group by time interaction in the three second average

peak blood flow (p = 0.30) or the three second average peak shear rate (p = 0.30) (Blood
flow SIT: pre-, 787 ± 300: post 1008 ± 398; Control: pre-, 824 ± 258: post, 837 ± 101
mlmin-1), (Shear rate SIT: pre-, 406 ± 150: post, 535 ± 198: Control: pre-, 575 ± 207:
post, 600± 85.0 s-1). There was no main effect for group (blood flow: p = 0.59), (shear
rate: p = 0.59) or time (blood flow: p = 0.24), (shear rate: p = 0.24).
4.16

Peak Blood Flow Measures (30 second average)
There was no significant group by time interaction in the 30 second average peak

blood flow (p = 0.16) or the 30 second average shear rate (p = 0.36) (Blood flow SIT:
pre-, 614 ± 259: post 764 ± 299; Control: pre-, 576 ± 158: post, 624 ± 77.0 mlmin-1),
(Shear rate SIT: pre-, 300 ± 123: post, 390 ± 140: Control: pre-, 318 ± 113: post, 316 ±
71.0 s-1). There was no main effect for group (blood flow: p = 0.37), (shear rate: p = 0.55)
or time (blood flow: p = 0.19), (shear rate: p = 0.24).
4.17

Peak Diameter
Likewise, there was no significant group by time interaction (p = 0.21) in peak

SFA diameter (SIT: pre-, 7.24 ± 0.68: post, 7.13 ± 0.47; Control: pre-, 6.99 ± 0.30: post,
7.17 ± 0.52 mm). There was no main effect for group (p = 0.67) or time (p = 0.78).
4.18
4.18.1

Flow Mediated Dilation
FMD
There was no significant group by time interaction (p =0.47) in %FMD (SIT: pre-,

4.9 ± 3.7: post, 4.9 ± 3.0; Control: pre-, 3.7 ± 1.7: post, 5.5 ± 2.7 %). There was no main
effect for group (p = 0.92) or time (p = 0.33).
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4.18.2

FMD: Peak (normalized)
There was no significant group by time interaction (p =0.38) in %FMD

normalized for peak shear rate (SIT: pre-, 0.018 ± 0.017134: post, 0.014 ± 0.011;
Control: pre-, 0.014 ± 0.012: post, 0.019 ± 0.012 a u ). There was no main effect for
group (p = 0.93) or time (p = 0.99).
4.18.3

FMD: AUC (normalized)
There was no significant group by time interaction (p = 0.93) in %FMD:AUC

(SIT: pre-, 0.002 ± 0.002: post, 0.002 ± 0.001; Control: pre-, 0.002 ± 0.003: post, 0.002 ±
0.001a u). There was no main effect for group (p = 0.83) or time (p = 0.80).
4.18.4

FMD: AUC15-45 s (normalized)
There was no significant group by time interaction (p = 0.47) in %FMD:AUC 15-

45 (SIT: pre-, 0.005 ± 0.009: post, 0.004 ± 0.003; Control: pre-, 0.004 ± 0.003: post,
0.005 ± 0.003 a u ). There was no main effect for group (p = 0.90) or time (p = 0.96).
4.18.5

Time to Peak Dilation
There was no significant group by time interaction (p = 0.09) in TTPD (SIT: pre-,

146 ± 78: post, 104 ± 73; Control: pre-, 110 ± 78: post, 165 ± 89 s). There was no main
effect for group (p = 0.52) or time (p = 0.97).
4.18.6

Area under the Shear Rate Curve (AUCSR)
There was no significant group by time interaction (p = 0.93) in area under the

shear rate curve (AUCSR) (SIT: pre-, 3684.7 ± 2630.9: post, 3813.8 ± 2021.2; Control:
pre-, 3477.4 ± 2270.6: post, 3486.8 ± 1089.5 s-1). There was no main effect for group (p
= 0.76) or time (p = 0.92).
4.19

Challenges with Pre- and Post Testing Time
Men: AM vs PM (Diurnal effects)
There was no diurnal effects between groups (AM vs PM) in any hemodynamic

or endothelial function measure (See Table 3). There was no main effect for group or
time (See Table 3).
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Table 3. Systematical analysis of the possible diurnal effects on testing measures (Male
participants only). Values are means±SD

MAP
(mmHg)
Baseline
Blood
flow
(mlmin1
)
Baseline
Shear
rate (s-1)
Baseline
diameter
(mm)
Peak
diameter
(mm)
Peak
flow: 30 s
average
(s-1)
Peak flow
3s
average ()
FMD (%)
Peak
Shear: 30
s average
(s-1)
Peak
Shear: 3 s
average
(s-1)
FMD:
Peak (s-1)
FMD:
AUC (s-1)
FMD:
AUC 1545 (s-1)
Time to
Peak
Dilation
(TTPD)

Testing time of Day (Group) vs. Time (pre-/post)
AM: Morning (n=11)
PM: Afternoon (n= 3)
Main effect
PrePost
PrePost
Interaction
Group
Time
82.2 ±
84.2 ± 9.6 78.3 ± 4.3 77.9 ± 5.4 P = 0.70
P = 0.37
P = 0.82
10.9
64 ± 19.7
101 ± 44.3 114.6 ±
113.3 ±
P = 0.11
P = 0.13
P = 0.14
28.9
39.1

33.1 ±
11.3

55.8 ±
25.6

69.4 ±
10.2

70.8 ±
28.8

P = 0.16

P = 0.03

P = 0.11

6.9 ± 0.5

6.8 ± 0.4

6.5 ± 0.6

6.5 ± 0.1

P = 0.64

P = 0.23

P = 0.52

7.3 ± 0.7

7.2 ± 0.5

6.8 ± 0.4

6.8 ± 0.2

P = 0.80

P = 0.27

P = 0.72

525.2 ±
177.3

755.6 ±
313.8

793.7 ±
358

712.2 ±
316.7

P = 0.17

P = 0.43

P = 0.50

698.4 ±
226.1

1010.9 ±
436.9

984.1 ±
448

892.9 ±
292

P = 0.18

P = 0.65

P = 0.45

4.4 ± 4.1
259.1 ±
100.8

5.3 ± 3.0
380.2 ±
145.5

5.0 ± 3.0
440 ±
126.7

4.9 ± 2.7
430.9 ±
166.4

P = 0.76
P = 0.25

P = 0.96
P = 0.09

P = 0.80
P = 0.31

359.5 ±
128.5

535.4 ±
225.7

567.6 ±
156.2

543 ±
142.5

P = 0.22

P = 0.23

P = 0.35

0.02 ±
0.02
0.001 ±
0.002
0.01 ±
0.01

0.02 ±
0.01
0.002 ±
0.002
0.004 ±
0.003

0.013 ±
0.012
0.001 ±
0.001
0.003 ±
0.003

0.013 ±
0.01
0.001 ±
0.001
0.003 ±
0.003

P = 0.77

P = 0.51

P = 0.77

P = 0.99

P = 0.47

P = 0.91

P = 0.75

P = 0.60

P = 0.81

163.6 ±
72.7

103.6 ±
76.3

120 ± 79.4

130 ± 69.2

P = 0.28

P = 0.81

P = 0.44
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Women: early vs. late effects.
Baseline Blood Flow measures
There was a significant group by time interaction (p = 0.05) in baseline blood
flow (Early: pre-, 47.3 ± 19.1: post, 67.2 ± 5.86; Late: pre-, 66.6 ± 28.5: post, 64.3 ± 21.8
mlmin-1) but no significant interaction (p = 0.08) in baseline shear rate (Early: pre-, 38 ±
19: post, 64 ± 28.8; Late: pre-, 56.2 ± 23.8: post, 58.3 ± 28 s-1). There was no main effect
for group (blood flow p = 0.76) (shear rare p = 0.40) but there was a main effect of time
(blood flow p = 0.01) (shear rate p = 0.01).
There was no significant group by time interaction (early vs. late) in any other
hemodynamic or endothelial function measures (See Table 4). There was no main effect
for group or time (See Table 4).
Table 4. Systematical analysis of the amount of days after the last SIT bout and post
testing measures due to menstrual cycle (female participants only). Values are
means±SD

MAP
(mmHg)
Baseline
Blood
flow
(mlmin1
)

Baseline
Shear
rate (s-1)
Baseline
diameter
(mm)
Peak
diameter
(mm)
Peak
flow: 30 s
average
(s-1)
Peak flow

Testing day after SIT (Group) vs. Time (pre-/post)
Early (1-4 days post
Late (5-14 days post
Main effect
SIT) (n= 5)
SIT (n= 9)
PrePost
PrePost
Interaction
Group
Time
87.6 ± 9.4 88.2 ± 6.4 83.9 ± 4.0 84.6 ± 5.8 P = 0.56
P = 0.71
P = 0.37
47.3 ± 19*

67.2 ± 5.9

66 ± 28.5

64 ± 21.8*

P = 0.05

P = 0.153

Tukey’s
HSD
Time
within late
P = 0.003

Tukey’s
HSD
Testing
day within
Pre P =
0.02

P = 0.01

38 ± 19.0

64 ± 28.8

56.2 ±
23.8

58.3 ± 28

P = 0.08

P = 0.40

P = 0.01

6.1 ± 0.5

5.8 ± 0.7

5.9 ± 0.5

5.8 ± 0.5

P = 0.87

P = 0.33

P = 0.26

6.4 ± 0.7

6.3 ± 0.6

6.1 ± 0.5

6.2 ± 0.5

P = 0.80

P = 0.62

P = 0.42

512.6 ±
209

764.3 ±
206.7

457.1 ±
174

575.7 ±
121

P = 0.50

P = 0.32

P = 0.12

734.5 ±

942 ± 245

640.8 ±

796.8 ±

P = 0.40

P = 0.48

P = 0.08
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3s
average ()
FMD (%)
Peak
Shear: 30
s average
(s-1)
Peak
Shear: 3 s
average
(s-1)
FMD:
Peak (s-1)
FMD:
AUC (s-1)
FMD:
AUC 1545 (s-1)
Time to
Peak
Dilation
(TTPD)

233.3

448

195.2

5.6 ± 3.6
363.2 ±
149.4

8.7 ± 3.4
560.2 ±
191.8

3.4 ± 2.6
374.3 ±
94.7

5.4 ± 2.6
464.4 ±
137.8

P = 0.98
P = 0.56

P = 0.28
P = 0.69

P = 0.82
P = 0.06

555.1 ±
169

843.5 ±
250.1

522.2 ±
102.5

694.7 ±
195.1

P = 0.39

P = 0.99

P = 0.06

0.02 ±
0.01
0.001 ±
0.001
0.01 ±
0.003

0.02 ±
0.01
0.002 ±
0.001
0.004 ±
0.002

0.01 ±
0.01
0.001 ±
0.001
0.002 ±
0.002

0.01 ±
0.01
0.002 ±
0.001
0.003 ±
0.002

P = 0.69

P = 0.11

P = 0.49

P = 0.95

P = 0.22

P = 0.88

P = 0.61

P = 0.22

P = 0.56

180 ± 70.4

60 ± 52

153 ± 69.5

73.3 ±
21.8

P = 0.66

P = 0.14

P = 0.12

45

Chapter 5

46

5

Discussion

5.1

Overview and Major Findings
The purpose of this study was to determine the effects of longer exercise bout (up

to 7 x 45 s) SIT protocol on superficial femoral artery (SFA) endothelial function and
hemodynamics in young healthy recreationally active men and women. To do so, flow
mediated dilation (FMD), blood flow, shear rate, vessel diameter, and time to peak
dilation after cuff release (TTPD) of the SFA was assessed in control and SIT groups
(separated by gender). A Finometer was used to collect mean arterial pressure (MAP). It
was hypothesized that the longer exercise bout (up to 7 x 45 s) SIT protocol would
improve endothelial function and hemodynamic properties of the SFA in the SIT group in
both men and women compared to the control group. The key findings of this research
study were that, despite observing no statistically significant changes in baseline shear,
baseline flow, baseline SFA diameter, MAP, peak SFA diameter, peak shear rate, shear
rate AUC, %FMD:AUC15-45, or peak blood flow, %flow mediated dilation (%FMD),
flow mediated dilation normalized by shear rate area under the curve (FMD:AUC), and
time to peak dilation all improved in the female SIT group compared to the control
female group. This suggests that endothelial function improved despite no significant
changes in baseline hemodynamics. In contrast, these findings were not observed in the
men; there were no statistically significant differences in the endothelial function and
hemodynamic measures between the male SIT group compared to the male control
group.
Specifically, the current study revealed that SIT increased %FMD in the women.
Similar results were also found in %FMD:AUC. This is important because %FMD:AUC
takes into account the differences in shear stimulus between each person and normalizes
the shear stimulus across the group. Likely, %FMD normalized for the shear stimulus is
a more definitive measure of endothelial function (Pyke & Tschakovsky, 2005). These
findings are very interesting because there was no statistically significant increase in
peak, area under the curve (AUC), or baseline shear rate between the SIT group and the
control group. However, time to peak dilation after cuff release decreased significantly
in the SIT group but not in the control group. Thus, SIT improved endothelial function
(via %FMD, FMD:AUC) and improved the SFA vasodilatory response to the shear rate
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stimulus (via decrease TTPD). In addition, because the NO is the endothelial derived
releasing factor that often mediates the vasodilatory response of arteries, these data
suggest that SIT might produce an increased NO bioavailability and/or an increased NO
sensitivity in the SFA endothelium in the women studied. Interestingly, the same
response was not apparent in the male participants.
A possible explanation for inconsistencies in endothelial dependent improvements
in the women compared to men in the current study may be related to differences in
oxidative stress. Specifically, Laughlin and Roseguini (2008) suggest that the elevated
oxidative stress and inflammatory response after high intensity exercise training may
blunt the shear stress and hemodynamic mediated beneficial adaptations of exercise. This
observation is important because even though, SIT is a self-limiting “all out” effort; the
men’s absolute speeds were on average 4 km faster than the women. Consequently, the
men may have reached a higher threshold of oxidative stress and thus, had a greater
inflammatory response after SIT. If so, this could blunt any enhancement in endothelial
function (Bergholm et al., 1999; Laughlin & Roseguini, 2008). However, this is not
likely as relative exercise intensity determines oxidative stress. Previous studies have
characterized the intensity of SIT at upwards of 250 percent of VO2max (Burgomaster,
Heigenhauser, & Gibala, 2006) so it is reasonable to suspect that SIT would be associated
with significant oxidative stress (Bergholm et al., 1999; Goto et al., 2003). However,
Goto and colleagues (2003) measured oxidative stress in men after 12 weeks of
endurance training (70-80% of VO2max) and reported an increase in oxidative stress
without endothelial dysfunction, although at much lower exercise intensity than the
current study. Regardless, the idea that increased oxidative stress can elicit endothelial
dysfunction needs future study especially because there is also evidence that high
intensity exercise improves antioxidant defenses against oxidative stress (Atalay et al.,
1996; Bloomer, 2007; Elosua et al., 2003; Gomez-Cabrera, Vina, & Ji, 2009; Sen, Atalay,
& Hanninen, 1994). Other possible explanations for the observed gender inconsistencies
include structural (changes in resting artery diameter) adaptations in the artery,
differences in the time course of both structural and functional changes in the artery,
and/or perhaps even differences in pre-study training status.
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Classically, structural arterial remodeling with exercise is characterized by
increased resting artery diameter (Langille & O'Donnell, 1986; Rodbard, 1975) but is
likely assessed more accurately via ischemic handgrip exercise or nitroglycerin
vasodilation methodology (Naylor et al., 2005). In 2008, Tinken and colleagues used
both, the maximal artery diameter vasodilation technique (Naylor et al., 2005) and the
FMD technique to assess structural and functional arterial changes in the brachial and
popliteal artery every two weeks over eight weeks of moderate exercise training (cycling
and running for 30 minutes at 80% of heart rate reserve) in healthy men, respectively
(Tinken et al.,2008). Tinken and colleagues reported that arterial structure (remodeling)
and arterial function (endothelial function) were significantly improved in both the
popliteal and brachial artery after two and four weeks of exercise training when
compared to baseline. These increases in arterial function persisted all the way out to
week six in the popliteal artery. However, at week eight arterial function in both arteries
returned to baseline levels. Interestingly, maximal arterial diameter (structural
remodeling) was statistically greater compared to baseline after two weeks and persisted
all the way out to week eight of exercise training. These time course data validate the
hypothesis proposed earlier by Laughlin and colleagues, that functional vascular
adaptations precede structural remodeling (Laughlin et al., 1996) and are of relevance
here because structural remodeling (that normalizes shear stress) likely would abolish any
improvement in vascular function measured with FMD. As mentioned, SFA functional
changes were not observed in the men in our study. However, of course, the SIT studied
was much more intense than the exercise training used in the Tinken et al. (2008) study.
Perhaps the intensity of the SIT drove rapid (occurring at week two and four) endothelial
function improvements in the SFA of men in our SIT group that then returned to baseline
by week six. If this was the case, the post measure assessment of endothelial function (via
FMD) after six weeks of SIT would yield no changes in endothelial function, despite
endothelial function improvements at week two and four. Unfortunately, Tinken and
colleagues did not include women participants in their study so no gender comparison is
possible (Tinken et al., 2008); however, increased circulating estrogen concentrations
have been associated with an increased NO synthase (Hayashi et al., 1995).
Consequently, fluctuating estrogen concentrations across the menstrual cycle may affect
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the time course of adaptation to SIT exercise -induced structural and functional arterial
changes in young women when compared to young men. Future studies are needed to
confirm these observations.
Interestingly, structural and functional adaptations are not limited to the arteries of
the dominant exercising muscle (Clarkson et al., 1999; Green et al., 2004). These studies
have demonstrated that brachial endothelial function can be improved following lower
body exercise. Further, others observed a significant increase in peak forearm blood flow
during bicycle training, which included very minimal upper limb movement (Silber,
McLaughlin, & Sinoway, 1991). They concluded that the vascular adaptations to training
are not specific to the limb involved in the exercise and that training adaptations may be
dependent upon the amount of mass muscle involved (Silber, McLaughlin, & Sinoway,
1991). Of course, our study involved a very large muscle mass but we did not assess
brachial artery endothelial function. Despite, the lower body dominant exercise of SIT,
assessment of the brachial artery might have been informative. However, a recent
retrospective analysis of the relationship between vasodilatory function in upper and
lower limbs revealed that upper limb vasodilator function in healthy humans may not be
predictive of that of the lower limbs (Thijssen, Rowley et al., 2011). Importantly, this
study assessed baseline resting vascular function (via FMD) in young untrained men
(Thijssen, Rowley et al., 2011) which, as mentioned, may not be an accurate
representation of the endothelial adaptations that occur throughout the entire vasculature
of healthy men with training. Clearly much more work is necessary to sort this all out.
Regardless, functional adaptations might occur in conduit arteries of muscle not
predominantly involved in the exercise training.
As previously mentioned, exercise training leads to an increased bioavailability of
NO (Laughlin & Roseguini, 2008) and NO bioavailability is an important marker of
endothelial dependent function. Interestingly, NO bioavailability may be vessel
dependent (Green et al.,, 2004; Green et al., 2011; Thijssen et al., 2010). Larger conduit
vessels have a greater capacity for NO production (Laughlin et al., 2003a; Laughlin et al.,
2003b). Furthermore, if NO bioavailability is vessel dependent, it may also be variable
from person to person. Green and colleagues suggest that differences in baseline vascular
function may provide insight into the inconsistencies in outcomes of endothelial function

50

in healthy populations (Green et al., 2011). The current study did not assess participants
based on baseline vascular function. Rather, participants were grouped based on sex and
assigned randomly to either the SIT group or the control group. Grouping the participants
based on sex and baseline vascular function is likely an approach that would add clarity
to the current findings.
Interestingly, training status as well as sport specificity may also alter NO
bioavailability. Studies performed on the arteries of athletes and physically fit
individuals suggest that exercise training induces larger arterial diameters than their age
matched controls (Green et al., 2012). Furthermore, limb dominant sport athletes such as
tennis and squash players, have larger arterial diameters in their dominant arm (Green et
al.,1996; Naylor et al., 2006; Sinoway et al., 1986; Zeppilli et al., 1995). However,
enhanced arterial function (via FMD) was not significantly greater in the arteries of
athletes compared to controls. Green and colleagues suggest that functional changes in
the arteries of well-trained individuals may have already been determined due to previous
arterial remodeling (Green et al.,, 2011). In the current study young recreationally active
men and women were recruited. Their level of physical activity was assessed using a
participant survey (Appendix A). Of the 21 female participants only one was a varsity
level athlete. Conversely, eight of the 15 male SIT group participants and three of the six
male control group participants were involved in highly competitive rugby, soccer, mixed
martial arts, weightlifting, and/or rowing prior to our SIT study. Despite, the emphasis
placed on all participants eliminating all other sources of training besides the SIT for the
six weeks of the experiment; it is possible that the men’s previous training status caused
chronic arterial remodeling (larger SFA diameter). If so, the arterial remodeling would
likely normalize the SIT induced shear stress, and could explain the observed no change
in endothelial function (via FMD) in the male participants. This is possible because
popliteal artery endothelium function improved in young inactive men and women (not
engaged in regular exercise more than 2 times X 30min per week for at least 1 year prior
to the study) with SIT (Rakobowchuk et al.,2008).
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5.2

Future Direction
To further document the endothelial functional adaptations of SIT in the SFA of

young recreationally healthy men and women research needs to focus on several areas.
First, both the structural and functional vascular adaptations of the conduit arteries via
SIT need to be better understood. The use of maximal artery diameter measures to assess
vascular structural changes should help determine baseline vascular function in healthy
individuals. Likewise, a better grouping and assessment of prior training history of
participants would likely decrease confounding variability of training status on both
arterial vascular function and structural remodeling. Second, recent studies have focused
on the time course of vascular and structural adaptation of exercise training in young
healthy men (Thijssen et al., 2010; Tinken et al.,, 2008). However, to our knowledge,
there are no research studies on the time course of functional and structural arterial
adaptations of exercise training in healthy young women so more study of women is
needed.
Third, to assess the more mechanistic side of SIT in vascular health, the use of
both in vivo and in vitro studies such as the studies by Hambrecht et al (2003) and
Laughlin et al. (1996) to determine the NO synthase protein expression, eNOS
phosphorylation, oxidative stress and antioxidants associated with SIT would likely help
decrease the discrepancies with endothelial function improvement and exercise in healthy
populations. This would establish if SIT induces an upregulation of NO synthase protein
by increasing phosphorylation of eNOS, as previously described by Hambrecht and
colleagues (2003) and/or if there are oxidative and antioxidant species that play a role in
vascular adaptations at the cellular level. The ability to establish arterial NO
bioavailability prior to exercise training would be another interesting approach to
establishing baseline vascular function.
Fourth, increases in blood flow patterns induce shear stress. Blood flow patterns
consist of both antegrade (forward) and retrograde (backward) flow and both are variable.
Recently, several studies (Green et al., 2005; Thijssen et al., 2009; Tinken et al., 2009)
investigated whether lower body exercise induced changes in blood flow patterns
(amount of retrograde and antegrade blood flow) affect the upper limb endothelial
function and reported an increase in NO release. Others suggest that higher intensity
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exercise produces increased blood flow and shear rate that may result in different
endothelial adaptations compared to less intense exercise (Thijssen et al., 2010).
Moreover, endothelial cell phenotype (a cell’s ability to integrate and transduce stimuli
from its surrounding environment) is sensitive to flow and shear stress patterns; so it is
likely that different exercise intensity stimuli may result in different endothelial
adaptations (Laughlin & Roseguini, 2008; Laughlin, Newcomer, & Bender, 2008). Future
SIT investigations should assess both upper and lower limb vascular function, as well as
retrograde and antegrade blood flow patterns in order to provide a better understanding of
any systemic vascular or endothelial (phenotype) adaptations.
5.3

Limitations
One investigator manually took all the artery diameter measurements. Three

diameter measures were taken and then averaged to represent the artery diameter during
the diastolic portion of the cardiac cycle. Several studies suggest that manual analysis is
subject to substantial observer error (Black, Cable, Thijssen, & Green, 2008). The gold
standard for diameter measurement is the use of computerized Edge detection software
(Black, Cable, Thijssen, & Green, 2008; Thijssen., 2011) but this software was not
available for this study. However, despite this limitation statistically significant changes
were found in %FMD and FMD:AUC suggesting that the manual diameter measurements
were sensitive enough to detect change.
Peak shear rate (averaged over three seconds) increased over time from pre- to
post measures for all female participants. This suggests that there was no difference in
peak shear rate after cuff release between the SIT group and the control group. However,
this significant increase in peak shear rate may be due to measurement error as follows.
During the FMD technique, a cuff is placed around the lower leg to occlude the SFA
artery. Upon release of the cuff following five minutes of occlusion, the ultrasound
technician must be able to quickly adjust the probe to the new position of the artery. The
ability to quickly adjust the probe to the new artery position without losing the detection
of blood flow is a skill that improves with repetition. So it is possible that the increase in
peak shear rate (averaged over three seconds) was due to improvement in probe
placement technique during the post training measurements.
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5.3.1

Challenges with the VO2peak Measures
As previously mentioned SIT is a time efficient mode of training that has

produced many similar adaptations when compared to more traditional endurance
training. Previous studies with SIT have shown increases in VO2PEAK/MAX after four and six
weeks (Burgomaster et al., 2005; Burgomaster et al., 2007; Gibala et al., 2006; Hazell et
al., 2010; Macpherson, Hazell et al., 2011; Rakobowchuk et al., 2008). Furthermore,
most studies with SIT and high intensity exercise training only used four to six sets of 30
s exercise bouts and still saw a significant increase in VO2PEAK/MAX (Burgomaster et al.,
2005; Burgomaster et al., 2007; Gibala et al., 2006; Hazell et al.,2010; Macpherson et al.,
2011; Rakobowchuk et al., 2008). The current study used a longer duration SIT protocol,
with sprint bouts increasing from 30 to 45 s and sets of sprints increasing from six to
seven repetitions of sprints. The male SIT group increased their VO2PEAK significantly
after six weeks of SIT when compared to the control group but the women did not. The
female participants results were likely affected by the smaller sample size as four female
(two from the SIT group and two from the control) were removed due to injury, lack of
adherence to the SIT protocol, and data that was lost due to technical error (corrupted
files). Furthermore, of the four females in the control group, three participants improved
their VO2peakwhich is not representative of a typical control group. Likely, the
aforementioned limitations (smaller sample size and control group improvements)
contributed to a type II statistical error. As a result, a one way ANOVA was performed
on the SIT group for the VO2peak data and revealed a significant training effect.
Regardless, a recent exercise training study by Tinken et al. (2008) saw enhanced
endothelial function with only a modest change in VO2max.
5.3.2

Challenges with Pre- and Post Testing Time
Due to changes in schedules, there were inconsistencies in the pre- and post

testing of 3 male participants. This is important, as diurnal effects have been observed on
FMD measurements (Harris et al., 2010). However, statistical analysis of the FMD
measures between those tested in the morning and those tested in the afternoon in our
study revealed no significant differences. This suggests that the variability of the testing
time of the 3 male participants did not confound the FMD measures.
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Lastly, to be able to control for the effects of estrogen on FMD, the female
participants were pre- and post tested during the early follicular phase of the menstrual
cycle. Controlling for the effects of estrogen on FMD, created variability in the number
of days between the last sprint interval exercise bout and the post testing measures. For
example, five females were post tested early (1 to 4 days) after their last sprint interval
exercise bout and nine females were tested late (5 to 14 days) after their last sprint
interval exercise bout. Statistical analyses revealed a decrease in baseline blood flow
(post SIT) in the females tested late (5-14) that was statistically significant. Interestingly,
none of these results (late testing vs. early testing) were in conflict with the previously
described female results (SIT vs. control: increased FMD, FMD:AUC and decreased TTP
dilation). Suggesting that the variability with the testing time after SIT (due to the
menstrual cycle) did not add confounding variability to measures of endothelial function.
5.4

Summary and Conclusion
Currently, western society has reached a level of physical inactivity that far

outweighs prior generations (Booth, Chakravarthy, & Spangenburg, 2002). Further, it is
clear that physical inactivity is a risk factor for various cardiovascular diseases such as
atherosclerosis. Likely, disease of conduit arteries as assessed via endothelial
dysfunction is an early manifestation of atherosclerosis (Vita, 2005). Several studies
have revealed that endurance exercise training is an intervention that can improve
endothelial vascular function in a diseased or at risk population (Green et al., 2004;
Maiorana et al., 2003; Moyna & Thompson, 2004; Walsh et al., 2003). However, studies
on exercise training and endothelial vascular function in healthy populations are far less
common and the results are inconsistent (Green et al., 2011). Further, there is a large void
of research on the effects of exercise training on the endothelial vascular function of
young healthy women. Interestingly, moderate intensity endurance exercise is used
commonly as the training stimulus to improve endothelial function in both healthy and
diseased populations, despite research that denotes many similar and/or greater training
adaptations with SIT (Burgomaster, Heigenhauser, & Gibala, 2006; Green et al., 2011;
Macpherson et al.,2011; Maiorana et al., 2001; Thijssen et al., 2011; Tinken et al., 2010).
However, high intensity exercise training induces greater oxidative stress, which could be
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positive (via its increased antioxidant defense) or negative (via blunted endothelial
function) (Atalay et al., 1996; Bloomer, 2007; Elosua et al., 2003; Gomez-Cabrera, Vina,
& Ji, 2009; Laughlin & Roseguini, 2008; Sen, Atalay, & Hanninen, 1994).
The current study examined the effects of SIT on endothelial vascular function
(via FMD) in 41 young recreationally active men and women. It was hypothesized that
the longer exercise bout (up to 7 x 45 s) SIT protocol would improve SFA endothelial
function and hemodynamic properties. In the women, SIT decreased time to peak
dilation and increased flow mediated dilation. Surprisingly, SIT had no effect on any
endothelial function or hemodynamic measures in the men.
These results suggest that SIT improved endothelial vascular function in young
recreationally active women. This improvement could be due to changes in the NO
response. The observed gender difference may be due to differences in the men’s
baseline vascular function attributed to exercise training status, greater oxidative stress,
and/or vascular structural remodeling that prevented endothelial vascular functional
improvements in the male participants. Future studies on the effects of SIT on
endothelial vascular function in young healthy individuals are needed to establish the
blood flow pattern (retrograde and antegrade) associated with SIT, in order to quantify
any associated shear stress stimulus as well as to document whether increases in
endothelial phenotype sensitivity contribute to different vascular adaptations.
Longitudinal training studies that include measures of vascular structural remodeling
would be welcomed to assess possible gender differences in structural and vascular
adaptations with time.
In conclusion, six weeks of SIT improved endothelial function (perhaps mediated
by increased NO response) in young women. However, six weeks of SIT did not improve
endothelial function in young men.
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Appendix A

Participant Information
Subject I.D.: ____________

Date: _________________

Age: ___________________ Height: _______________

Weight: _______________

Smoker: Yes / No
_____________________

Ethnic Background:

Medical History (please check any and all that apply)
Family history of heart disease
Heart murmur
Phlebitis
Other heart disorder (please specify)

□
□
□
□

__________________________
Family history of stroke
□
Migraines
Sinus problems
□
Hypertension
Diabetes
Raynaud’s syndrome
Polycystic ovary syndrome
Seizures
Digestive problems
Asthma
□
Bronchitis
Other respiratory disorder (please specify)

□
□
□
□
□
□
□
□
□

__________________________
Have you ever fainted?

Yes / No

If yes, under what circumstances:

_______________________________________________
_____
Are you taking any medications?

Yes / No

If yes, please specify: ____________________________________________________________
Have you consumed alcohol or any caffeinated beverages in the last 12 hours?

Yes / No

If yes, please specify the quantity: __________________________________________________
Have you had any major surgeries, illnesses or injuries? Yes / No
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If yes, please specify (include dates): _______________________________________________
Are you physically active?
Yes / No
If yes, please specify the type, frequency, and typical duration of exercise:
______________________________________________________________________________
How long have you been physically active?
______________________________________________________________________________

Age of menarche:

__________________
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Appendix C
Letter of Information
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1

LETTER OF INFORMATION REGARDING RESEARCH
Title of Study:

The effect of sprint interval training on selected cardiovascular
measures and exercise performance in men and women

You are being invited to participate in a research study conducted by P.W.R. Lemon
(PhD), Stephanie Reid (BSc), Alan Smith (BSc), Terry Olver (MSc), Alex Stevens
(BHK), and Craig Hamilton (BSc), from the Exercise Nutrition Research Laboratory in
the School of Kinesiology at the University of Western Ontario.
If you have any questions or concerns about the research, please feel free to contact
Stephanie, Alan, Terry, Alex or Craig at XXXXXXX or Dr. Lemon XXXXXXX
PURPOSE OF THE STUDY
The purpose of this research experiment is to determine if six weeks of sprint interval
training (SIT) will improve selected cardiovascular measures and exercise performance
in men and women.
INCLUSION/EXCLUSION CRITERIA
In order to be eligible to participate in this study you must be a healthy, 18 to 35 year old
male or female.
You will be excluded from this study if you are: injured, diabetic, currently undergoing a
similar training program or have any contraindications to this type of exercise.
PROCEDURES
If you volunteer to participate in this study, we will ask you to do the following things:
1. Complete a health survey (PAR-Q) to assess your current physical capability.
2. Record a 3-day dietary record for the weeks that pre- and post-training testing
are completed.
3. Undergo an assessment of various cardiovascular and exercise measures,
before and after training, that will include: determination of body composition
(BodPod® - involves sitting comfortably in a chamber for about 5 minutes while
the space your body takes up is measured), a multi-stage exercise test on a
treadmill (maximal oxygen uptake test), blood pressure, femoral blood flow,
cardiac output, pulse wave velocity, blood velocity, arterial compliance, femoral
artery diameter, heart rate, and a 5 minute run on a manually driven treadmill.
Version 2 (08/30/2011)

_____
Initials

78

2
4. Complete 6 weeks of sprint interval training (3 days/week). Each session will
consist of 4 (wk 1 and 2), 5 (wk 3 and 4), or 6 (wk 5 and 6) 1 minute “all out”
running efforts on a manually driven treadmill, with each effort separated by 4
minutes of no exercise.
Testing will be conducted in the Exercise Nutrition Research Laboratory, the
Neurovascular Research Laboratory, and the Canadian Centre for Activity and Aging.
Females will be tested during the beginning of the menstrual cycle to ensure hormone
levels are consistent during testing. Women will be asked to keep track of their
menstrual cycle so that testing will occur during the first seven days of the menstrual
cycle. Whereby, the first day of menstruation marks day one of the menstrual cycle.
TIME INVOLVED
The study will take place over eight weeks. There will be six weeks of training and 2
weeks of testing (pre- and post-training).
Pre- and post-training testing will take place during the first and eighth week of the study
and will take place over 4 days. Day one will involve being familiarized with the
procedures that will be done and completion of a dietary record. On day two, body
composition and maximal oxygen uptake tests will be completed. On day three, resting
cardiovascular measures will be taken (blood pressure, femoral blood flow, cardiac
output, pulse wave velocity, blood velocity, arterial compliance, and femoral artery
diameter). On day four, a 5 minute run on a manually driven treadmill will be completed.
Training will take place from week 2 to week 7. It will occur 3 days per week. The
number of intervals per session will increase over the course of the training program.
Subjects will complete 4 intervals per session during weeks 2 and 3, 5 intervals during
weeks 4 and 5, and 6 intervals during weeks 6 and 7. At the end of weeks 3 and 5
subjects will be reassessed for changes in resting cardiovascular measures (blood
pressure, femoral blood flow, and cardiac output). A recovery drink will be given after
each training session.
POTENTIAL RISK AND DISCOMFORTS
All exercise involves some health risk (primarily cardiovascular or hydration-related) but
lack of activity has been shown to more hazardous to one’s health. Further, these
concerns are much reduced in young, healthy individuals. This type of exercise is
completed by many Western students in kinesiology classes, in intramural sports, and
by Mustang athletes. Participants will be encouraged to adequately hydrate. There are
no risks associated with the finger cuff method for measuring blood pressure. When the
cuff is inflated subjects may experience numbness but this is reversed immediately
upon deflation of the cuff. Adhesive electrodes will be applied to the skin for ECG.
Some individuals may experience a slight skin reaction in response to the adhesive.
This typically clears up in a few days. There are no known risks associated with
ultrasound.
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This typically clears up in a few days. There are no known risks associated with
ultrasound.
POTENTIAL BENEFITS
Your aerobic fitness will likely improve using this training protocol. Society may benefit
from this study. It is unknown how SIT affects cardiovascular health measures. If we
find SIT to be beneficial to cardiovascular health this would provide people with an
alternate, effective mode of training.
COMPENSATION
You will not be compensated for your participation in this study.
CONFIDENTIALITY
Any information that is obtained in connection with this study that can identify you will
remain confidential and will be disclosed only with your permission. This information will
be collected on a master list that will be kept in a password protected file with access to
only the investigators in this study. All data will be collapsed before results are printed
(only group averages and variability). All participants will be assigned an arbitrary
number to ensure anonymity. Mean data will be stored in a password protected file for
comparison with future studies. Raw data will not be released to any other parties.
PARTICIPATION AND WITHDRAWAL
You can choose whether to be in this study or not. If you are a student and you
volunteer, you may withdraw at any time without any effect on your status at UWO. If
you are not a student at UWO, you may withdraw from the study at any time. You may
also refuse to answer any questions you feel are inappropriate and still remain in the
study. The investigator may withdraw you from this research if circumstances arise
which warrant doing so. Participation in this study is voluntary.
FEEDBACK OF THE RESULTS OF THIS STUDY TO THE SUBJECTS
We plan to publish this study in a reputable academic journal upon the completion of the
research. The information published in a journal or subsequent studies will not identify
you in any way. Copies of such articles will be available upon request.

SUBSEQUENT USE OF DATA
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These data may be used in subsequent studies but the data will have no personal
identifiers.
You
will receive a copy of the consent form after it has been signed. You do not waive
any legal rights by signing the consent form.
You will receive a copy of the consent form after it has been signed. You do not waive
any legal rights by signing the consent form.
This letter is for you to keep. If you have any questions about this research project, feel
free to call us (Dr. Peter Lemon / Stephanie Reid, Alan Smith, Terry Olver, Alex Stevens
This
letter
is for you
to keep. If you
any questions
about
thishave
research
feel
or
Craig
Hamilton
–XXXXXXXX
for have
clarification.
Further,
if you
any project,
questions
free tothe
call
us (Dr.ofPeter
Lemon
Stephanie
Reid,
Alan Smith,
Terry
Olver,
Stevens
about
conduct
this study
or/ your
rights as
a research
subject
you
may Alex
contact
the
or Craig
519-661-2111
ext. 88164)
clarification.
if you have
any
Office
of Hamilton
Research –Ethics
at The University
of for
Western
OntarioFurther,
at XXXXXXXX
or at
questions about the conduct of this study or your rights as a research subject you may
XXXXX@uwo.ca.
contact the Office of Research Ethics at The University of Western Ontario at 519-6613036 or at ethics@uwo.ca.
Sincerely,
Sincerely,
Dr. Peter Lemon / Stephanie Reid / Alan Smith / Terry Olver / Alex Stevens /. Craig
Hamilton
Principal
Dr. PeterInvestigators
Lemon / Stephanie Reid / Alan Smith / Terry Olver / Alex Stevens /. Craig
RM
2235 3M Centre UWO, Exercise Nutrition Research Laboratory
Hamilton
Principal Investigators
RM 2235 3M Centre UWO, Exercise Nutrition Research Laboratory
plemon@uwo.ca, sreid73@uwo.ca, asmit92@uwo.ca tolver@uwo.ca,
asteve62@uwo.ca, chamilt@uwo.ca
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Appendix D
Consent to Participate in Research

5
INFORMED CONSENT STATEMENT
The effect of sprint interval training on selected cardiovascular measures and exercise
performance in men and women
Investigator: P.W.R. Lemon (Stephanie Reid and Alan Smith)
I have read the accompanying "Letter of Information”, have had the nature of the
study explained to me and I agree to participate. All questions have been
answered to my satisfaction.
By signing below, I agree to participate in this study.
Name of Participant (please print):
_______________________________________
Signature of Participant:
______________________________

Date: ______________________

Name of Person Obtaining Informed Consent:
_____________________________________
Signature of Person Obtaining Informed Consent:
________________________________

Date: ______________________

RE-RECRUITMENT IN FUTURE STUDIES
If you wish to participate in future studies in the Exercise Nutrition Research Lab, please
include your current contact information below.
I wish to be contacted for future studies in the Exercise Nutrition Research Laboratory.
Yes_____ (check mark), No _____ (check mark)
Date:______________________
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Post-secondary Education:
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2010-2012

Honours:

Western University
Western Graduate Research Scholarship
School of Kinesiology

Related Work Experience:

Graduate Teaching Assistant
The University of Western Ontario
2010-2012

Published Abstracts:
S.M. Reid, T.D. Olver, A.R. Smith, M. Zamir, J.K. Shoemaker and P.W.R. Lemon.
2011. Increases in forearm vascular compliance persist 2 h after sprint interval exercise in
young men. Applied Physiology, Nutrition, and Metabolism 36(S2):S348. (Abstract)
S.M. Reid, A.R. Smith, T.D. Olver, J.K. Shoemaker and P.W.R. Lemon. 2012. Six
Weeks of Sprint Interval Training Speeds Flow-Mediated Dilation in Women.
Med.Sci.Sports Exerc, 44(S5):S2 (Abstract)
S.M. Reid, A.R. Smith, T.D. Olver, P.W.R. Lemon and J.K. Shoemaker. 2012.
Sprint interval training decreases viscoelastic and inertial effects in forearm vasculature
in young men. Western University, Exercise Nutrition Research Laboratory, London,
Canada N6A 3K7. Submitted to CSEP for October 2012 conference

